<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="psp413046" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">CPT Pharmacometrics Syst Pharmacol</journal-id><journal-id journal-id-type="iso-abbrev">CPT Pharmacometrics Syst Pharmacol</journal-id><journal-id journal-id-type="pmc-domain-id">2038</journal-id><journal-id journal-id-type="pmc-domain">cptpsp</journal-id><journal-id journal-id-type="publisher-id">PSP4</journal-id><journal-title-group><journal-title>CPT: Pharmacometrics &amp; Systems Pharmacology</journal-title></journal-title-group><issn pub-type="epub">2163-8306</issn><publisher><publisher-name>Wiley</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10725272</article-id><article-id pub-id-type="pmcid-ver">PMC10725272.1</article-id><article-id pub-id-type="pmcaid">10725272</article-id><article-id pub-id-type="pmcaiid">10725272</article-id><article-id pub-id-type="pmid">37700716</article-id><article-id pub-id-type="doi">10.1002/psp4.13046</article-id><article-id pub-id-type="publisher-id">PSP413046</article-id><article-id pub-id-type="other">PSP-2023-0090</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Research</subject><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group></subj-group></article-categories><title-group><article-title>Model&#8208;based assessment of neutrophil&#8208;mediated phagocytosis and digestion of bacteria across in vitro and in vivo studies</article-title><alt-title alt-title-type="right-running-head">Neutrophil&#8208;mediated killing of bacteria</alt-title><alt-title alt-title-type="left-running-head">Thorsted et al.</alt-title></title-group><contrib-group><contrib id="psp413046-cr-0001" contrib-type="author"><name name-style="western"><surname>Thorsted</surname><given-names initials="A">Anders</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1804-2703</contrib-id><xref rid="psp413046-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="psp413046-cr-0002" contrib-type="author"><name name-style="western"><surname>Pham</surname><given-names initials="AD">Anh Duc</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0279-1761</contrib-id><xref rid="psp413046-curr-0001" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="psp413046-cr-0003" contrib-type="author"><name name-style="western"><surname>Friberg</surname><given-names initials="LE">Lena E.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2979-679X</contrib-id><xref rid="psp413046-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="psp413046-cr-0004" contrib-type="author" corresp="yes"><name name-style="western"><surname>Nielsen</surname><given-names initials="EI">Elisabet I.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0725-214X</contrib-id><xref rid="psp413046-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>elisabet.nielsen@farmaci.uu.se</email></address></contrib></contrib-group><aff id="psp413046-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Pharmacy</named-content>
<institution>Uppsala University</institution>
<city>Uppsala</city>
<country country="SE">Sweden</country>
</aff><aff id="psp413046-curr-0001"><label>
<sup>2</sup>
</label>Present address:
<named-content content-type="organisation-division">Leiden Academic Centre for Drug Research</named-content>
<institution>Leiden University</institution>
<city>Leiden</city>
<country country="NL">The Netherlands</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Elisabet I. Nielsen, Department of Pharmacy, Box 580, Uppsala 751 23, Sweden.<break/>
Email: <email>elisabet.nielsen@farmaci.uu.se</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>16</day><month>10</month><year>2023</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2023</year></pub-date><volume>12</volume><issue seq="140">12</issue><issue-id pub-id-type="pmc-issue-id">451182</issue-id><issue-id pub-id-type="doi">10.1002/psp4.v12.12</issue-id><fpage>1972</fpage><lpage>1987</lpage><history><date date-type="rev-recd"><day>30</day><month>8</month><year>2023</year></date><date date-type="received"><day>24</day><month>4</month><year>2023</year></date><date date-type="accepted"><day>01</day><month>9</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>16</day><month>10</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>17</day><month>12</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-01-29 03:25:23.260"><day>29</day><month>01</month><year>2024</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2023 The Authors. <italic toggle="yes">CPT: Pharmacometrics &amp; Systems Pharmacology</italic> published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="PSP4-12-1972.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:PSP4-12-1972.pdf"/><abstract><title>Abstract</title><p>Neutrophil granulocytes are key components of the host response against pathogens, and severe neutropenia, with neutrophil counts below 0.5 &#215;&#8201;10<sup>6</sup> cells/mL, renders patients increasingly vulnerable to infections. Published in vitro (<italic toggle="no">n</italic>&#8201;=&#8201;7) and in vivo (<italic toggle="no">n</italic>&#8201;=&#8201;5) studies with time&#8208;course information on bacterial and neutrophil counts were digitized to characterize the kinetics of neutrophil&#8208;mediated bacterial killing and inform on the immune systems' contribution to the clearance of bacterial infections. A mathematical model for the in vitro dynamics of bacteria and the kinetics of neutrophil&#8208;mediated phagocytosis and digestion was developed, which was extended to in vivo studies in immune&#8208;competent and immune&#8208;compromised mice. Neutrophil&#8208;mediated bacterial killing was described by two first&#8208;order processes&#8212;phagocytosis and digestion&#8212;scaled by neutrophil concentration, where 50% of the maximum was achieved at neutrophil counts of 1.19 &#215;&#8201;10<sup>6</sup> cells/mL (phagocytosis) and 6.55 &#215;&#8201;10<sup>6</sup> cells/mL (digestion). The process efficiencies diminished as the phagocytosed bacteria to total neutrophils ratio increased (with 50% reduction at a ratio of 3.41). Neutrophil in vivo dynamics were captured through the characterization of myelosuppressive drug effects and postinoculation neutrophil influx into lungs and by system differences (27% bacterial growth and 9.3% maximum capacity, compared with in vitro estimates). Predictions showed how the therapeutically induced reduction of neutrophil counts enabled bacterial growth, especially when falling below 0.5 &#215;&#8201;10<sup>6</sup> cells/mL, whereas control individuals could deal with all tested bacterial burdens (up to 10<sup>9</sup>&#8201;colony forming units/g lung). The model&#8208;based characterization of neutrophil&#8208;mediated bacterial killing simultaneously predicted data across in vitro and in vivo studies and may be used to inform the capacity of host&#8211;response at the individual level.</p></abstract><counts><fig-count count="5"/><table-count count="2"/><page-count count="16"/><word-count count="7009"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>December 2023</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.3.6 mode:remove_FC converted:16.12.2023</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="PSP413046-cit-2001"><string-name name-style="western"><surname>Thorsted</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Pham</surname><given-names>AD</given-names></string-name>, <string-name name-style="western"><surname>Friberg</surname><given-names>LE</given-names></string-name>, <string-name name-style="western"><surname>Nielsen</surname><given-names>EI</given-names></string-name>. <article-title>Model&#8208;based assessment of neutrophil&#8208;mediated phagocytosis and digestion of bacteria across in vitro and in vivo studies</article-title>. <source>CPT Pharmacometrics Syst Pharmacol</source>. <year>2023</year>;<volume>12</volume>:<fpage>1972</fpage>&#8208;<lpage>1987</lpage>. doi:<pub-id pub-id-type="doi">10.1002/psp4.13046</pub-id><pub-id pub-id-type="pmcid">PMC10725272</pub-id><pub-id pub-id-type="pmid">37700716</pub-id></mixed-citation>
</p><fn-group id="psp413046-ntgp-0001"><fn id="psp413046-note-0001"><p>Anders Thorsted and Anh Duc Pham contributed equally to this work.</p></fn></fn-group></notes></front><body id="psp413046-body-0001"><p>
<boxed-text position="anchor" content-type="box" orientation="portrait"><caption><title>Study Highlights</title></caption><p>
<list list-type="simple" id="psp413046-list-0001"><list-item id="psp413046-li-0011"><p>
<bold>WHAT IS THE CURRENT KNOWLEDGE ON THE TOPIC?</bold>
</p></list-item></list>
</p><p>Neutrophils are important contributors to the host's innate immune response against pathogens, but low counts render the host vulnerable to infections.
<list list-type="simple" id="psp413046-list-0002"><list-item id="psp413046-li-0012"><p>
<bold>WHAT QUESTION DID THIS STUDY ADDRESS?</bold>
</p></list-item></list>
</p><p>This study integrates in vitro and in vivo data in a modeling framework to study neutrophil&#8208;mediated bacterial killing and the relationships between neutrophil and bacterial counts in terms of clearance or manifestation of an infection.
<list list-type="simple" id="psp413046-list-0003"><list-item id="psp413046-li-0013"><p>
<bold>WHAT DOES THIS STUDY ADD TO OUR KNOWLEDGE?</bold>
</p></list-item></list>
</p><p>This study provides quantitative insights into the neutrophil&#8211;bacterial axis, and may serve as a&#160;translational link&#160;between in vitro and in vivo studies.
<list list-type="simple" id="psp413046-list-0004"><list-item id="psp413046-li-0014"><p>
<bold>HOW MIGHT THIS CHANGE DRUG DISCOVERY, DEVELOPMENT, AND/OR THERAPEUTICS?</bold>
</p></list-item></list>
</p><p>The results improve the understanding of preclinical data for antibiotic drug development, specifically the contribution of the innate immune response in studies with immune&#8208;competent mice.</p></boxed-text>
</p><sec id="psp413046-sec-0003"><title>INTRODUCTION</title><p>Neutrophils play a key role in the host innate immune response against invading pathogens.<xref rid="psp413046-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref>, <xref rid="psp413046-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> Granulopoiesis by hematopoietic bone marrow cells generate up toward 2 &#215;&#8201;10<sup>11</sup> neutrophils per day, which circulate with a half&#8208;life of 6&#8211;8&#8201;h.<xref rid="psp413046-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref> The normal blood neutrophil range in humans is defined as 1.5&#8211;8.0 &#215;&#8201;10<sup>6</sup> cells/mL. Neutropenia, a blood neutrophil count below 1.5 &#215;&#8201;10<sup>6</sup> cells/mL, is associated with an increased infection risk and more severe infections.<xref rid="psp413046-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>, <xref rid="psp413046-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref> Among typical pathogens found in neutropenic patients, often with respiratory or blood stream infections, are the gram&#8208;negatives <italic toggle="yes">Escherichia coli</italic>, <italic toggle="yes">Klebsiella</italic> species, <italic toggle="yes">Pseudomonas aeruginosa</italic>, and <italic toggle="yes">Acinetobacter baumannii</italic> and the gram&#8208;positives <italic toggle="yes">Staphylococcus epidermidis</italic> and <italic toggle="yes">Staphylococcus aureus</italic>.<xref rid="psp413046-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>, <xref rid="psp413046-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref>
</p><p>Infection occurs when an invading pathogen takes residence in the sterile tissues of a host and starts to proliferate. Pathogen associated molecular patterns are recognized immediately by the host innate immune system, which engages to liberate the body of the invader. Pathogens are marked with opsonin molecules to facilitate phagocytosis, either by the complement arm of the innate immune system (by opsonin molecules C4b, C3b, and C3bi) or by immunoglobulin G antibodies, which enable phagocyte recognition by way of complement or Fc receptors.<xref rid="psp413046-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>, <xref rid="psp413046-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="psp413046-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref>, <xref rid="psp413046-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> Eradication proceeds through the internalization of the pathogen (phagocytosis) and the breakdown of the internalized matter (&#8220;digestion&#8221;). Phagocytosis triggers at the cell membrane through stimulation of initiating receptors, which leads to intracellular activation and formation of pseudopodia (arm&#8208;like extensions) and an engulfed phagosome, after which intracellular granules containing reactive oxygen species and enzymes digest the phagosome.<xref rid="psp413046-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="psp413046-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>
</p><p>Neutropenia is often a complication in cancer patients who receive myelosuppressive chemotherapy, as dividing hematopoietic cells are affected in addition to the targeted cancerous cells.<xref rid="psp413046-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref> The Common Terminology Criteria for Adverse Events defines increasingly severe neutropenia (Grades 2 to 4) as &#8805;1.0 to &lt;1.5 &#215;&#8201;10<sup>6</sup> cells/mL, &#8805;0.5 to &lt;1.0 &#215;&#8201;10<sup>6</sup> cells/mL, and &lt;0.5 &#215;&#8201;10<sup>6</sup> cells/mL. To avoid prolonged neutropenia and the increased risk of opportunistic infections and sepsis, neutrophils should recover prior to a next chemotherapeutic dose administration, with treatment decisions possibly guided by predictive models.<xref rid="psp413046-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref>, <xref rid="psp413046-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>
</p><p>Typically, antimicrobial drugs are administered to assist a compromised (or functioning) immune system in combating an infection. However, the host response component is usually disregarded during pharmacokinetic/pharmacodynamic (PKPD) assessment of antibiotics, and its effect relative to that of the administered antibiotic(s) is undetermined, although it may be profound.<xref rid="psp413046-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>, <xref rid="psp413046-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> Although large variability may exist between individuals, all sustain a degree of phagocytic capacity, which warrants further investigation of the relation between bacterial concentration and neutrophil&#8208;mediated killing capacity. Application of mechanism&#8208;based mathematical PKPD modeling has been shown to offer substantial value for optimized antimicrobial therapy by allowing description of the full time courses of drug disposition, bacterial growth, antibiotic killing, and resistance development.<xref rid="psp413046-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> In a model&#8208;based analysis, data from different sources (e.g., in vitro, in vivo, clinical) can be combined to establish a translational framework, which furthers understanding and quantification of differences and similarities between settings.<xref rid="psp413046-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> To expand these models, and to also integrate a quantitative assessment of the interaction between pathogen and the host immune system, has recently been highlighted as a prioritized research area and a step toward successful prediction of individual patient outcomes and clinical trial results.<xref rid="psp413046-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>
</p><p>The aim of this work was to use mathematical modeling to characterize the kinetics of neutrophil&#8208;mediated phagocytosis and digestion of bacteria to quantify the ability of the immune system to eradicate different degrees of bacterial burdens. Specifically, neutrophil&#8208;mediated killing was characterized across varying neutrophil and bacterial concentrations (in vitro studies) and extended to describe neutrophil and bacterial time courses in immune&#8208;competent and compromised mice (in vivo studies).</p></sec><sec sec-type="materials-and-methods" id="psp413046-sec-0004"><title>MATERIALS AND METHODS</title><p>A literature search was performed to identify studies describing temporal dynamics of neutrophils and bacteria. Studies that used pathogenic bacteria and reported bacterial (colony forming units [CFU]) or neutrophil concentration over time were included. Studies performed in vitro should use &#8805;5% human serum (for opsonization) and a temperature of 37&#176;C, whereas in vivo studies should be performed using a murine pneumonia model. The identified studies, listed in Table&#160;<xref rid="psp413046-tbl-0001" ref-type="table">1</xref>, comprised seven in vitro and five in vivo studies with information relevant for the intended modeling work.</p><table-wrap position="float" id="psp413046-tbl-0001" content-type="TABLE" orientation="portrait"><label>TABLE 1</label><caption><p>Overview of included in vitro and in vivo studies, including the bacterial species, type of bacterial measurement (in vitro), mouse strain (in vivo), bacterial start inoculum, static neutrophil concentration (in vitro) or site of measurement (in vivo), study setup and duration, and reference.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Study</th><th align="left" valign="bottom" rowspan="1" colspan="1">Bacteria</th><th align="left" valign="bottom" rowspan="1" colspan="1">Bacteria measurement</th><th align="left" valign="bottom" rowspan="1" colspan="1">Inoculum (CFU/mL)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Neutrophil levels (cells/mL)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Study setup (duration)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Reference</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">In vitro&#8208;1</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Staphylococcus epidermidis</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Total</td><td align="left" valign="top" rowspan="1" colspan="1">10<sup>3</sup>, 10<sup>5</sup>, 10<sup>7</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">0; 1, 4, 8 &#215;&#8201;10<sup>5</sup>; 1, 2, 4 &#215;&#8201;10<sup>6</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">In vitro suspension (0&#8211;1.5&#8201;h)</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="psp413046-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">In vitro&#8208;2</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">S. epidermidis</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Total</td><td align="left" valign="top" rowspan="1" colspan="1">10<sup>3</sup>, 10<sup>5</sup>, 10<sup>6</sup>, 10<sup>7</sup>, 10<sup>8</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">0; 2, 4 &#215;&#8201;10<sup>5</sup>; 1, 2, 4 &#215;&#8201;10<sup>6</sup>; 1 &#215;&#8201;10<sup>7</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">In vitro fibrin gel (0&#8211;1.5&#8201;h)</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="psp413046-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">In vitro&#8208;3</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Staphylococcus aureus</italic>, <italic toggle="yes">Escherichia coli</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Extracellular</td><td align="left" valign="top" rowspan="1" colspan="1">10<sup>6</sup>, 10<sup>7</sup>, 10<sup>8</sup>, 10<sup>9</sup>, 10<sup>10</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">0; 5 &#215;&#8201;10<sup>6</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">In vitro suspension (0&#8211;2&#8201;h)</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="psp413046-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">In vitro&#8208;4</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">S. aureus</italic>, <italic toggle="yes">E. coli</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Intracellular</td><td align="left" valign="top" rowspan="1" colspan="1">10<sup>5</sup>, 10<sup>6</sup>, 10<sup>7</sup>, 10<sup>8</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">5 &#215;&#8201;10<sup>6</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">In vitro suspension (0&#8211;2&#8201;h)</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="psp413046-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">In vitro&#8208;5</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">S. aureus</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Total</td><td align="left" valign="top" rowspan="1" colspan="1">10<sup>6</sup>, 10<sup>7</sup>, 10<sup>8</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">5 &#215;&#8201;10<sup>6</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">In vitro suspension (0&#8211;2&#8201;h)</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="psp413046-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">In vitro&#8208;6</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">S. aureus</italic>, <italic toggle="yes">Streptococcus pyogenes</italic>, <italic toggle="yes">Corynebacterium</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Intracellular</td><td align="left" valign="top" rowspan="1" colspan="1">10<sup>5</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">1 &#215;&#8201;10<sup>6</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">In vitro suspension (0&#8211;3&#8201;h)</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="psp413046-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">In vitro&#8208;7</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">S. aureus</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Total</td><td align="left" valign="top" rowspan="1" colspan="1">10<sup>4</sup>, 10<sup>6</sup>, 10<sup>7</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">0; 2.5, 5, 7.5 &#215;&#8201;10<sup>5</sup>; 1, 4.4 &#215;&#8201;10<sup>6</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">In vitro suspension (0&#8211;1&#8201;h)</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="psp413046-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>
</td></tr></tbody></table><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Study</th><th align="left" valign="bottom" rowspan="1" colspan="1">Bacteria</th><th align="left" valign="bottom" rowspan="1" colspan="1">Mouse (weeks)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Inoculum (CFU/g)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Neutrophils (site)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Study setup &amp; data range</th><th align="left" valign="bottom" rowspan="1" colspan="1">Reference</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Mice&#8208;1</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Acinetobacter baumannii</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">C57BL/6 (7&#8211;9)</td><td align="left" valign="top" rowspan="1" colspan="1">5.71 &#215;&#8201;10<sup>6</sup>, 5.71 &#215;&#8201;10<sup>7</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">In vivo pneumonia (0&#8211;72&#8201;h)</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="psp413046-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mice&#8208;2</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">A. baumannii</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Swiss&#8208;Webster (&#8722;)</td><td align="left" valign="top" rowspan="1" colspan="1">1.57 &#215;&#8201;10<sup>7</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">Blood</td><td align="left" valign="top" rowspan="1" colspan="1">In vivo pneumonia (0&#8211;24&#8201;h, cyclophosphamide pretreated)</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="psp413046-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mice&#8208;3</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">A. baumannii</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">C57BL/6 (8&#8211;12)</td><td align="left" valign="top" rowspan="1" colspan="1">5.71 &#215;&#8201;10<sup>6</sup>, 5.71 &#215;&#8201;10<sup>7</sup>, 5.71 &#215;&#8201;10<sup>8</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">In vivo pneumonia (0&#8211;96&#8201;h)</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="psp413046-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mice&#8208;4</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">A. baumannii</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">C57BL/6 (8&#8211;12)</td><td align="left" valign="top" rowspan="1" colspan="1">~1.71 &#215;&#8201;10<sup>8</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">Lung</td><td align="left" valign="top" rowspan="1" colspan="1">In vivo pneumonia (0&#8211;168&#8201;h)</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="psp413046-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mice&#8208;5</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">C57BL/6 (6&#8211;12)</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">Blood, lung</td><td align="left" valign="top" rowspan="1" colspan="1">Tissue neutrophils (steady state)</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="psp413046-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref>
</td></tr></tbody></table><table-wrap-foot id="psp413042-ntgp-0001"><fn id="psp413042-note-0001"><p>Abbreviation: CFU, colony forming unit.</p></fn></table-wrap-foot></table-wrap><p>The in vitro experiments, either performed in liquid or gel media, were done at one fixed neutrophil concentration but with varying bacterial inoculum<xref rid="psp413046-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref>, <xref rid="psp413046-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>, <xref rid="psp413046-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>, <xref rid="psp413046-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref> or by varying both the bacterial inoculum and the neutrophil concentration.<xref rid="psp413046-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>, <xref rid="psp413046-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref>, <xref rid="psp413046-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref> Bacterial concentrations (CFU/mL) were quantified by bacterial plating, followed by incubation and counting of CFUs. Two studies specifically assessed neutrophil digestion, by first exposing bacteria to neutrophils before removal of extracellular bacteria.<xref rid="psp413046-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>, <xref rid="psp413046-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref> The quantified CFU then represented viable intracellular bacteria (i.e., phagocytosed but nondigested bacteria), with the difference reflecting digestion of phagocytosed bacteria. In one study, the viable extracellular bacteria were separated from neutrophils by centrifugation, with the quantified CFU representing viable nonphagocytosed bacteria.<xref rid="psp413046-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> The remaining studies lysed the neutrophils with sterilized water to release intracellular bacteria, and the quantified CFU represented the total viable CFU (i.e., nonphagocytosed and phagocytosed but nondigested).<xref rid="psp413046-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>, <xref rid="psp413046-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>, <xref rid="psp413046-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref>, <xref rid="psp413046-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref> One study was reserved for evaluation and not used for model building.<xref rid="psp413046-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>
</p><p>The in vivo experiments consisted of four studies of <italic toggle="yes">A. baumannii</italic> pneumonia<xref rid="psp413046-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref>, <xref rid="psp413046-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref>, <xref rid="psp413046-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref>, <xref rid="psp413046-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref> and one study that quantified neutrophil concentrations in tissues (without bacteria).<xref rid="psp413046-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref> In one study, mice were pretreated with cyclophosphamide (50/50, 100/50, 200/150&#8201;mg/kg, or vehicle 96 and 24&#8201;h prior to inoculation) to reduce the circulating neutrophil count, which was assumed to impact the postinoculation neutrophil influx and thus CFU time course in lung.<xref rid="psp413046-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref> Three studies described the bacterial time course in lung of immune&#8208;competent mice,<xref rid="psp413046-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref>, <xref rid="psp413046-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref>, <xref rid="psp413046-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref> and one also informed on the time course of neutrophils and alveolar macrophages in lung.<xref rid="psp413046-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref> At specified times after inoculation, mice were euthanized and the lungs were carefully dissected and homogenized prior to plating. The units of the digitized observations were transformed from CFU/lung or CFU/mL to CFU/g by considering the dilution volume and/or an approximate lung weight of 0.175&#8201;g in C57BL/6 mice.<xref rid="psp413046-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref> The reported bacterial inoculum was also transformed (from CFU to CFU/g).</p><sec id="psp413046-sec-0005"><title>Software</title><p>Graphical data points representing longitudinal bacteria or neutrophil were digitized by use of Engauge digitizer (Version 12.1). The statistical software R (Version 4.0.2) was used for data visualization and model predictions using packages tidyverse (Version 1.3.1)<xref rid="psp413046-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref> and RxODE (Version 1.1.2).<xref rid="psp413046-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref> Model development was conducted with NONMEM (Version 7.5.0) using the first&#8208;order conditional estimation method facilitated by Perl&#8208;speaks&#8208;NONMEM and Xpose 4 (Version 4.7.1).<xref rid="psp413046-bib-0033" ref-type="bibr">
<sup>33</sup>
</xref> The computations were enabled by the Swedish National Infrastructure for Computing (SNIC) at UPPMAX, by resources in the project SNIC 2021/5&#8208;552.</p></sec><sec id="psp413046-sec-0006"><title>Model development</title><p>Data were converted to log<sub>10</sub> scale and modeled with additive residual error using the transform&#8208;both&#8208;sides approach. As a starting point, separate models were developed for relevant subsets of the in vitro data in the following order: (i) bacterial growth (without neutrophils), (ii) neutrophil digestion of phagocytosed bacteria,<xref rid="psp413046-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>, <xref rid="psp413046-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref> and (iii) neutrophil phagocytosis of bacteria. In each step, the parameters relating to the previous model(s) were fixed with a simultaneous estimation of the combined in vitro model as a final step.</p><p>To describe the in vivo data, the established in vitro model was extended to a model for neutrophil dynamics after cancer chemotherapy.<xref rid="psp413046-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref>, <xref rid="psp413046-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref> Development proceeded in steps to account for (i) drug&#8208;induced change in circulating neutrophils, (ii) neutrophil (and macrophage) time course in lungs upon bacterial deposition, and (iii) CFU time course in lung after bacterial deposition. Structural and numerical (parameter estimates) differences between in vitro and in vivo studies were assessed before a final simultaneous fit with in vitro and in vivo parameters unfixed.</p></sec><sec id="psp413046-sec-0007"><title>Bacterial in vitro dynamics</title><p>A published structural model was adopted to describe bacterial dynamics, separating bacteria into growing (S) and resting (R) states.<xref rid="psp413046-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref> In this model, total CFU count is governed by first&#8208;order rate constants describing growth (k<sub>growth</sub>) and natural death (k<sub>death</sub>) and by a maximum carrying density (B<sub>max</sub>), with transfer from S to R defined as k<sub>SR</sub>&#8201;=&#8201;(S&#8201;+&#8201;R)&#8729;(k<sub>growth</sub>&#8211;k<sub>death</sub>)/B<sub>max</sub>.</p><p>Bacterial growth controls displayed a growth delay, and a lag state (L) was added.<xref rid="psp413046-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref>, <xref rid="psp413046-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref>, <xref rid="psp413046-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref> Because of the limited data and short duration of experiments (&#8804;3&#8201;h), the first&#8208;order natural bacterial death rate constant was fixed to 0.179&#8201;h<sup>&#8722;1</sup>, and k<sub>RS</sub> was fixed to 0&#8201;h<sup>&#8722;1</sup> (determined based on more informative data in the original publication of the model).<xref rid="psp413046-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref> B<sub>max</sub> was fixed to 2.5&#183;10<sup>9</sup>&#8201;CFU/mL, representing the highest digitized CFU. All bacteria started in the L state and transitioned to the S state (by first&#8208;order rate constant k<sub>lag</sub>) while being subjected to natural death (k<sub>death</sub>). The bacterial system was defined by:<disp-formula id="psp413046-disp-0001"><label>(1)</label><mml:math id="jats-math-1" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mfrac><mml:mi mathvariant="normal">dL</mml:mi><mml:mrow><mml:mi mathvariant="normal">d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mo>&#8722;</mml:mo><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mtext>death</mml:mtext></mml:msub><mml:mo>&#183;</mml:mo><mml:mi mathvariant="normal">L</mml:mi><mml:mo>&#8722;</mml:mo><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mi>lag</mml:mi></mml:msub><mml:mo>&#183;</mml:mo><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:mrow></mml:math></disp-formula>
<disp-formula id="psp413046-disp-0002"><label>(2)</label><mml:math id="jats-math-2" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mfrac><mml:mi>dS</mml:mi><mml:mrow><mml:mi mathvariant="normal">d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo linebreak="goodbreak">=</mml:mo><mml:mo linebreak="goodbreak">&#8722;</mml:mo><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mtext>death</mml:mtext></mml:msub><mml:mo>&#183;</mml:mo><mml:mi mathvariant="normal">S</mml:mi><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mi>lag</mml:mi></mml:msub><mml:mo>&#183;</mml:mo><mml:mi mathvariant="normal">L</mml:mi><mml:mo linebreak="goodbreak">&#8722;</mml:mo><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mi>SR</mml:mi></mml:msub><mml:mo>&#183;</mml:mo><mml:mi mathvariant="normal">S</mml:mi><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mtext>growth</mml:mtext></mml:msub><mml:mo>&#183;</mml:mo><mml:mi mathvariant="normal">S</mml:mi></mml:mrow></mml:mrow></mml:math></disp-formula>
<disp-formula id="psp413046-disp-0003"><label>(3)</label><mml:math id="jats-math-3" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mfrac><mml:mi mathvariant="normal">dR</mml:mi><mml:mrow><mml:mi mathvariant="normal">d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mo>&#8722;</mml:mo><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mtext>death</mml:mtext></mml:msub><mml:mo>&#183;</mml:mo><mml:mi mathvariant="normal">R</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mi>SR</mml:mi></mml:msub><mml:mo>&#183;</mml:mo><mml:mi mathvariant="normal">S</mml:mi></mml:mrow></mml:mrow></mml:math></disp-formula>
</p></sec><sec id="psp413046-sec-0008"><title>Neutrophil in vitro phagocytosis and digestion</title><p>Neutrophils were assumed to eliminate bacteria according to two first&#8208;order processes, with estimated rate constants for phagocytosis (k<sub>N,phag</sub> from all three states: L, S, and R) and subsequent intracellular digestion (k<sub>N,dig</sub>).<xref rid="psp413046-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref> Both processes were assumed to have a maximum capacity (k<sub>N,max,phag</sub>, k<sub>N,max,dig</sub>) related to the neutrophil concentration (N) through linear, maximum effect [E<sub>max</sub>], or sigmoidal E<sub>max</sub> models (with estimated potency parameters N<sub>50,phag</sub> and N<sub>50,dig</sub>).<xref rid="psp413046-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref> As each neutrophil has the capacity for a finite number of bacteria, links were tested between decreasing phagocytosis and digestion rates with an increase in the ratio of phagocytosed bacteria to total neutrophils (P/N, with 50% reduction at estimated ratios P/N<sub>50,phag</sub> and P/N<sub>50,dig</sub>).<xref rid="psp413046-bib-0036" ref-type="bibr">
<sup>36</sup>
</xref> Time&#8208;related decreases in phagocytosis and digestion were assessed (k<sub>N,loss,phag</sub>, k<sub>N,loss,dig</sub>), potentially related to decreased opsonisation, overall system fatigue, and a loss of cells.<xref rid="psp413046-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>, <xref rid="psp413046-bib-0037" ref-type="bibr">
<sup>37</sup>
</xref> Parameterizations for neutrophil phagocytosis and digestion are given in Equations&#160;(<xref rid="psp413046-disp-0004" ref-type="disp-formula">4</xref>) and (<xref rid="psp413046-disp-0005" ref-type="disp-formula">5</xref>), whereas the number of bacteria in the neutrophil&#8208;phagocytosed state (P<sub>N</sub>) is captured by Equation&#160;(<xref rid="psp413046-disp-0006" ref-type="disp-formula">6</xref>):<disp-formula id="psp413046-disp-0004"><label>(4)</label><mml:math id="jats-math-4" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="left"><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mrow><mml:mi mathvariant="normal">N</mml:mi><mml:mo>,</mml:mo><mml:mtext>phag</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mrow><mml:mi mathvariant="normal">N</mml:mi><mml:mo>,</mml:mo><mml:mi>max</mml:mi><mml:mo>,</mml:mo><mml:mtext>phag</mml:mtext></mml:mrow></mml:msub><mml:mo>&#183;</mml:mo><mml:mi mathvariant="normal">N</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="normal">N</mml:mi><mml:mrow><mml:mn>50</mml:mn><mml:mo>,</mml:mo><mml:mtext>phag</mml:mtext></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi mathvariant="normal">N</mml:mi></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>&#183;</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mn>1</mml:mn><mml:mo>&#8722;</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">N</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mo>/</mml:mo><mml:msub><mml:mi mathvariant="normal">N</mml:mi><mml:mrow><mml:mn>50</mml:mn><mml:mo>,</mml:mo><mml:mtext>phag</mml:mtext></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi mathvariant="normal">P</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">N</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="left"><mml:mspace width="4em"/><mml:mo>&#183;</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mo>&#8722;</mml:mo><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mrow><mml:mi mathvariant="normal">N</mml:mi><mml:mo>,</mml:mo><mml:mtext>loss</mml:mtext><mml:mo>,</mml:mo><mml:mtext>phag</mml:mtext></mml:mrow></mml:msub><mml:mo>&#183;</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced></mml:msup></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math></disp-formula>
<disp-formula id="psp413046-disp-0005"><label>(5)</label><mml:math id="jats-math-5" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="left"><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mrow><mml:mi mathvariant="normal">N</mml:mi><mml:mo>,</mml:mo><mml:mi>dig</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mrow><mml:mi mathvariant="normal">N</mml:mi><mml:mo>,</mml:mo><mml:mi>max</mml:mi><mml:mo>,</mml:mo><mml:mi>dig</mml:mi></mml:mrow></mml:msub><mml:mo>&#183;</mml:mo><mml:mi mathvariant="normal">N</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="normal">N</mml:mi><mml:mrow><mml:mn>50</mml:mn><mml:mo>,</mml:mo><mml:mi>dig</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi mathvariant="normal">N</mml:mi></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>&#183;</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mn>1</mml:mn><mml:mo>&#8722;</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">N</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mo>/</mml:mo><mml:msub><mml:mi mathvariant="normal">N</mml:mi><mml:mrow><mml:mn>50</mml:mn><mml:mo>,</mml:mo><mml:mi>dig</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi mathvariant="normal">P</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">N</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="left"><mml:mspace width="4em"/><mml:mo>&#183;</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mo>&#8722;</mml:mo><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mrow><mml:mi mathvariant="normal">N</mml:mi><mml:mo>,</mml:mo><mml:mtext>loss</mml:mtext><mml:mo>,</mml:mo><mml:mi>dig</mml:mi></mml:mrow></mml:msub><mml:mo>&#183;</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced></mml:msup></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math></disp-formula>
<disp-formula id="psp413046-disp-0006"><label>(6)</label><mml:math id="jats-math-6" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi>dP</mml:mi><mml:mi mathvariant="normal">N</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi mathvariant="normal">d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mrow><mml:mi mathvariant="normal">N</mml:mi><mml:mo>,</mml:mo><mml:mtext>phag</mml:mtext></mml:mrow></mml:msub><mml:mo>&#183;</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mi mathvariant="normal">L</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">R</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">S</mml:mi></mml:mrow></mml:mfenced><mml:mo>&#8722;</mml:mo><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mrow><mml:mi mathvariant="normal">N</mml:mi><mml:mo>,</mml:mo><mml:mi>dig</mml:mi></mml:mrow></mml:msub><mml:mo>&#183;</mml:mo><mml:msub><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">N</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math></disp-formula>
</p></sec><sec id="psp413046-sec-0009"><title>Neutrophil in vivo dynamics</title><p>The cyclophosphamide&#8208;driven reduction in circulating neutrophils was described by a semimechanistic model for myelosuppressive drug effects in rats.<xref rid="psp413046-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref> No structural changes were made to the model, but parameters were scaled to mice through allometric scaling by weight using weights of 0.025&#8201;kg (mice) and 0.295&#8201;kg (rats) and exponents of 0.75, 1.0, and &#8722;0.25 for cyclophosphamide clearance (CL), volume of distribution (V), and first&#8208;order absorption&#8208;rate constant (k<sub>abs</sub>), respectively.<xref rid="psp413046-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref>, <xref rid="psp413046-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref>, <xref rid="psp413046-bib-0038" ref-type="bibr">
<sup>38</sup>
</xref> The parameter describing neutrophil maturation time (MTT; with k<sub>tr</sub>&#8201;=&#8201;4/MTT) was scaled (exponent of 0.25) and the systemic feedback factor (<italic toggle="yes">&#947;</italic>) was fixed to 0.149 (rat estimate, unitless), whereas the drug&#8208;effect slope (D<sub>SLP</sub>) and circulating neutrophil concentration at baseline (N<sub>circ,T0</sub>) were estimated from the data.<xref rid="psp413046-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref> Cyclophosphamide concentration in plasma (CP<sub>pl</sub>/V) was predicted by mono&#8208;exponential absorption (from the absorption compartment, CP<sub>abs</sub>, following intraperitoneal injection) and elimination (k<sub>el</sub>&#8201;=&#8201;CL/V) in Equations&#160;(<xref rid="psp413046-disp-0007" ref-type="disp-formula">7</xref>) and (<xref rid="psp413046-disp-0008" ref-type="disp-formula">8</xref>), with neutrophil dynamics described by Equations&#160;(<xref rid="psp413046-disp-0009" ref-type="disp-formula">(9)</xref>, <xref rid="psp413046-disp-0010" ref-type="disp-formula">(10)</xref>, <xref rid="psp413046-disp-0011" ref-type="disp-formula">(11)</xref>, <xref rid="psp413046-disp-0012" ref-type="disp-formula">(12)</xref>, <xref rid="psp413046-disp-0013" ref-type="disp-formula">(13)</xref>):<disp-formula id="psp413046-disp-0007"><label>(7)</label><mml:math id="jats-math-7" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">d</mml:mi><mml:msub><mml:mi>CP</mml:mi><mml:mi>abs</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi mathvariant="normal">d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mo>&#8722;</mml:mo><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mi>abs</mml:mi></mml:msub><mml:mo>&#183;</mml:mo><mml:msub><mml:mi>CP</mml:mi><mml:mi>abs</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math></disp-formula>
<disp-formula id="psp413046-disp-0008"><label>(8)</label><mml:math id="jats-math-8" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">d</mml:mi><mml:msub><mml:mi>CP</mml:mi><mml:mi>pl</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi mathvariant="normal">d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mi>abs</mml:mi></mml:msub><mml:mo>&#183;</mml:mo><mml:msub><mml:mi>CP</mml:mi><mml:mi>abs</mml:mi></mml:msub><mml:mo>&#8722;</mml:mo><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mi>el</mml:mi></mml:msub><mml:mo>&#183;</mml:mo><mml:msub><mml:mi>CP</mml:mi><mml:mi>pl</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math></disp-formula>
<disp-formula id="psp413046-disp-0009"><label>(9)</label><mml:math id="jats-math-9" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="left"><mml:mfrac><mml:mrow><mml:msub><mml:mi mathvariant="normal">dN</mml:mi><mml:mtext>prol</mml:mtext></mml:msub></mml:mrow><mml:mrow><mml:mi mathvariant="normal">d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mo>&#8722;</mml:mo><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mi>tr</mml:mi></mml:msub><mml:mo>&#183;</mml:mo><mml:msub><mml:mi mathvariant="normal">N</mml:mi><mml:mtext>prol</mml:mtext></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mi>tr</mml:mi></mml:msub><mml:mo>&#183;</mml:mo><mml:msub><mml:mi mathvariant="normal">N</mml:mi><mml:mtext>prol</mml:mtext></mml:msub><mml:mo>&#183;</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mn>1</mml:mn><mml:mo>&#8722;</mml:mo><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mi>SLP</mml:mi></mml:msub><mml:mo>&#183;</mml:mo><mml:msub><mml:mi>CP</mml:mi><mml:mi>pl</mml:mi></mml:msub><mml:mo>/</mml:mo><mml:mi mathvariant="normal">V</mml:mi></mml:mrow></mml:mfenced></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="left"><mml:mspace width="5.7em"/><mml:mo>&#183;</mml:mo><mml:msup><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi mathvariant="normal">N</mml:mi><mml:mrow><mml:mtext>circ</mml:mtext><mml:mo>,</mml:mo><mml:mi mathvariant="normal">T</mml:mi><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>/</mml:mo><mml:msub><mml:mi mathvariant="normal">N</mml:mi><mml:mtext>circ</mml:mtext></mml:msub></mml:mrow></mml:mfenced><mml:mi>&#947;</mml:mi></mml:msup></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math></disp-formula>
<disp-formula id="psp413046-disp-0010"><label>(10)</label><mml:math id="jats-math-10" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi mathvariant="normal">dN</mml:mi><mml:mrow><mml:mi>tr</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi mathvariant="normal">d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mo>&#8722;</mml:mo><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mi>tr</mml:mi></mml:msub><mml:mo>&#183;</mml:mo><mml:msub><mml:mi mathvariant="normal">N</mml:mi><mml:mrow><mml:mi>tr</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mi>tr</mml:mi></mml:msub><mml:mo>&#183;</mml:mo><mml:msub><mml:mi mathvariant="normal">N</mml:mi><mml:mtext>prol</mml:mtext></mml:msub></mml:mrow></mml:mrow></mml:math></disp-formula>
<disp-formula id="psp413046-disp-0011"><label>(11)</label><mml:math id="jats-math-11" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi mathvariant="normal">dN</mml:mi><mml:mrow><mml:mi>tr</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi mathvariant="normal">d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mo>&#8722;</mml:mo><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mi>tr</mml:mi></mml:msub><mml:mo>&#183;</mml:mo><mml:msub><mml:mi mathvariant="normal">N</mml:mi><mml:mrow><mml:mi>tr</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mi>tr</mml:mi></mml:msub><mml:mo>&#183;</mml:mo><mml:msub><mml:mi mathvariant="normal">N</mml:mi><mml:mrow><mml:mi>tr</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></disp-formula>
<disp-formula id="psp413046-disp-0012"><label>(12)</label><mml:math id="jats-math-12" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi mathvariant="normal">dN</mml:mi><mml:mrow><mml:mi>tr</mml:mi><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi mathvariant="normal">d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mo>&#8722;</mml:mo><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mi>tr</mml:mi></mml:msub><mml:mo>&#183;</mml:mo><mml:msub><mml:mi mathvariant="normal">N</mml:mi><mml:mrow><mml:mi>tr</mml:mi><mml:mn>3</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mi>tr</mml:mi></mml:msub><mml:mo>&#183;</mml:mo><mml:msub><mml:mi mathvariant="normal">N</mml:mi><mml:mrow><mml:mi>tr</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></disp-formula>
<disp-formula id="psp413046-disp-0013"><label>(13)</label><mml:math id="jats-math-13" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:mspace width="0.25em"/><mml:msub><mml:mi mathvariant="normal">dN</mml:mi><mml:mtext>circ</mml:mtext></mml:msub></mml:mrow><mml:mrow><mml:mtext>d</mml:mtext><mml:mtext mathvariant="italic">t</mml:mtext></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mo>&#8722;</mml:mo><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mi>tr</mml:mi></mml:msub><mml:mo>&#183;</mml:mo><mml:msub><mml:mi mathvariant="normal">N</mml:mi><mml:mtext>circ</mml:mtext></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mi>tr</mml:mi></mml:msub><mml:mo>&#183;</mml:mo><mml:msub><mml:mi mathvariant="normal">N</mml:mi><mml:mrow><mml:mi>tr</mml:mi><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></disp-formula>
</p><p>Although Equations&#160;(<xref rid="psp413046-disp-0009" ref-type="disp-formula">(9)</xref>, <xref rid="psp413046-disp-0010" ref-type="disp-formula">(10)</xref>, <xref rid="psp413046-disp-0011" ref-type="disp-formula">(11)</xref>, <xref rid="psp413046-disp-0012" ref-type="disp-formula">(12)</xref>, <xref rid="psp413046-disp-0013" ref-type="disp-formula">(13)</xref>) were all initialized to N<sub>circ,T0</sub>, the neutrophil baselines in tissues are different, as neutrophil infiltration rate is tissue dependent.<xref rid="psp413046-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref> Additionally, neutrophils will migrate to the infected tissue, increasing the local neutrophil concentration.<xref rid="psp413046-bib-0039" ref-type="bibr">
<sup>39</sup>
</xref> These dynamics were incorporated by extending the previous model with a compartment representing lung neutrophils and by implementing a surge defined by amplitude (N<sub>AMP</sub>), width (N<sub>SW</sub>), and center (N<sub>T0</sub>) in the rate constant describing influx of neutrophils into lungs upon infection, described by:<disp-formula id="psp413046-disp-0014"><label>(14)</label><mml:math id="jats-math-14" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="left"><mml:mfrac><mml:mrow><mml:msub><mml:mi mathvariant="normal">dN</mml:mi><mml:mtext>lung</mml:mtext></mml:msub></mml:mrow><mml:mrow><mml:mi mathvariant="normal">d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mo>&#8722;</mml:mo><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mi>tr</mml:mi></mml:msub><mml:mo>&#183;</mml:mo><mml:msub><mml:mi mathvariant="normal">N</mml:mi><mml:mtext>lung</mml:mtext></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mi>tr</mml:mi></mml:msub></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="left"><mml:mspace width="5.9em"/><mml:mo>&#183;</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">N</mml:mi><mml:mi>AMP</mml:mi></mml:msub><mml:mo>/</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:msup><mml:mfenced close=")" open="("><mml:mrow><mml:mfenced close=")" open="("><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mo>&#8722;</mml:mo><mml:msub><mml:mi mathvariant="normal">N</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>/</mml:mo><mml:msub><mml:mi mathvariant="normal">N</mml:mi><mml:mi>SW</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mn>6</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced><mml:mo>&#183;</mml:mo><mml:msub><mml:mi mathvariant="normal">N</mml:mi><mml:mtext>circ</mml:mtext></mml:msub></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math></disp-formula>
</p><p>Similar dynamics were explored for lung alveolar macrophages.<xref rid="psp413046-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref>
</p></sec><sec id="psp413046-sec-0010"><title>Neutrophil in vivo phagocytosis</title><p>The processes of phagocytosis and digestion in vivo were assumed to be similar to the in vitro setup, although disregarding the lag in bacterial growth (i.e., bacteria starting directly in S) and loss of activity (i.e., k<sub>N,loss</sub>&#8201;=&#8201;0). Parameter differences between in vitro and in vivo systems were explored by assessing the statistical improvement in fit, starting with k<sub>growth</sub> and k<sub>N,max</sub>, and the presence of an additional in vivo phagocytic capability (e.g., lung alveolar macrophages) was evaluated (parametrized as in Equations&#160;<xref rid="psp413046-disp-0004" ref-type="disp-formula">(4)</xref>, <xref rid="psp413046-disp-0005" ref-type="disp-formula">(5)</xref>, <xref rid="psp413046-disp-0006" ref-type="disp-formula">(6)</xref>).</p></sec><sec id="psp413046-sec-0011"><title>Model evaluation</title><p>Nested models were compared through a likelihood ratio test of their objective function values (OFV), representing a statistical measure of fit, with a &#916;OFV&#8201;=&#8201;&#8722;3.84 considered statistically significant (&#945;&#8201;=&#8201;0.05) for one additional parameter. Additional assessments were (i) goodness&#8208;of&#8208;fit plots (comparing model predictions with observations and evaluating residuals over time), (ii) parameter uncertainty, and (iii) simulation&#8208;based visual predictive checks (VPCs).<xref rid="psp413046-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>, <xref rid="psp413046-bib-0040" ref-type="bibr">
<sup>40</sup>
</xref>
</p></sec><sec id="psp413046-sec-0012"><title>Model predictions</title><p>The established model was used to predict bacterial and neutrophil dynamics in 1000 individuals for three cyclophosphamide regimens (10&#8201;mg/kg every week [q1w], 20&#8201;mg/kg every 10&#8201;days [q10d], and 60&#8201;mg/kg every third week [q3w])<xref rid="psp413046-bib-0041" ref-type="bibr">
<sup>41</sup>
</xref> by using a published population pharmacokinetic model for cancer patients (assuming a body weight of 70&#8201;kg).<xref rid="psp413046-bib-0042" ref-type="bibr">
<sup>42</sup>
</xref> Interindividual variability (as percent coefficient of variation) was included in N<sub>circ,T0</sub> (20%) and MTT (15%), in CL (27%) and V (56%), and in the myelosuppressive drug effect (15%). Bacterial infections were simulated where a bacterial burden of 10<sup>6</sup> to 10<sup>9</sup>&#8201;CFU/g lung was added on Day 35, that is, at a time when neutrophils were predicted to approach the nadir.</p></sec></sec><sec sec-type="results" id="psp413046-sec-0013"><title>RESULTS</title><p>The digitized data (Table&#160;<xref rid="psp413046-tbl-0001" ref-type="table">1</xref>) included 115 in vitro experiments (403&#8201;CFU observations) and 21 in vivo experiments (56&#8201;CFU, 5 blood and 16 lung neutrophil observations). The final model structure is presented in Figure&#160;<xref rid="psp413046-fig-0001" ref-type="fig">1</xref>, and parameter estimates and uncertainties are presented in Table&#160;<xref rid="psp413046-tbl-0002" ref-type="table">2</xref>. The final NONMEM model code and data file are available as Data&#160;<xref rid="psp413046-supitem-0002" ref-type="supplementary-material">S2</xref> and Table&#160;<xref rid="psp413046-supitem-0001" ref-type="supplementary-material">S1</xref>. The digitized data and VPCs are shown in Figure&#160;<xref rid="psp413046-fig-0002" ref-type="fig">2</xref>, and external evaluation is shown in Figure&#160;<xref rid="psp413046-fig-0003" ref-type="fig">3</xref>.</p><fig position="float" fig-type="FIGURE" id="psp413046-fig-0001" orientation="portrait"><label>FIGURE 1</label><caption><p>Schematic of final model structure connecting the static (N<sub>tube</sub>) or dynamic (N<sub>lung</sub>) neutrophil concentration&#8211;time course to change in the concentration of bacteria. Bacteria exists in lag (L), growing (S), or resting (R) states and die naturally from all states according to the first&#8208;order rate constant k<sub>death</sub>. Bacteria in L transitions into S (k<sub>lag</sub>) where they replicate (k<sub>growth</sub>), and may transition further into R (k<sub>SR</sub>), dependent on the total number of bacteria (L&#8201;+&#8201;S&#8201;+&#8201;R) in the system in relation to the system carrying density (B<sub>max</sub>). Bacteria may be phagocytosed in vitro by neutrophils (k<sub>N,phag</sub>) and in vivo by neutrophils (k<sub>N,phag</sub>) and an additional phagocytic capacity (k<sub>M,phag</sub>, represented by a macrophage). Phagocytosis may occur from all three states (L, S, R) after which the bacteria, existing in a phagocytosed state (P<sub>N</sub> or P<sub>M</sub>), undergo digestion (by k<sub>N,dig</sub> or k<sub>M,dig</sub>). Deposition of bacteria in the lungs invokes a surge (described by amplitude [N<sub>AMP</sub>], time [N<sub>T0</sub>], and width [N<sub>SW</sub>]) in the rate at which circulating neutrophils (N<sub>circ</sub>) migrate to the lungs (N<sub>lung</sub>). The intraperitonially injected cyclophosphamide (CP<sub>abs</sub>) is absorbed into plasma (k<sub>abs</sub>) and eliminated from the system (k<sub>el</sub>). The cyclophosphamide plasma concentration (CP<sub>pl</sub>/V) is linked (D<sub>SLP</sub>) to kill neutrophil progenitors (N<sub>prol</sub>), which will (delayed by k<sub>tr</sub> through the neutrophil maturation transit chain N<sub>tr1</sub>&#8208;N<sub>tr3</sub>) impact the circulating (and by extension lung) neutrophil count.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="PSP4-12-1972-g001.jpg"/></fig><table-wrap position="float" id="psp413046-tbl-0002" content-type="TABLE" orientation="portrait"><label>TABLE 2</label><caption><p>Overview of parameter estimates and uncertainties for each submodel; the combined in vitro growth, phagocytosis, and digestion model; and the final model with simultaneous estimation of in vitro and in vivo models on the entire data set.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" colspan="2" style="border-bottom:solid 1px #000000" valign="bottom">Parameter (units)</th><th align="left" rowspan="2" style="border-bottom:solid 1px #000000" valign="bottom" colspan="1">Parameter description</th><th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Individual models</th><th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Combined in vitro</th><th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Final model</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Estimate</th><th align="left" valign="bottom" rowspan="1" colspan="1">(RSE%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Estimate</th><th align="left" valign="bottom" rowspan="1" colspan="1">(RSE%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Estimate</th><th align="left" valign="bottom" rowspan="1" colspan="1">(RSE%)</th></tr></thead><tbody valign="top"><tr><td align="left" colspan="9" valign="top" rowspan="1">Bacterial dynamics&#8212;in vitro</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">k<sub>growth</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1">(h<sup>&#8722;1</sup>)</td><td align="left" valign="top" rowspan="1" colspan="1">Bacterial first&#8208;order growth rate constant</td><td align="left" valign="top" rowspan="1" colspan="1">1.90</td><td align="left" valign="top" rowspan="1" colspan="1">(9.9)</td><td align="left" valign="top" rowspan="1" colspan="1">1.56</td><td align="left" valign="top" rowspan="1" colspan="1">(19)</td><td align="left" valign="top" rowspan="1" colspan="1">1.84</td><td align="left" valign="top" rowspan="1" colspan="1">(15)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">k<sub>death</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1">(h<sup>&#8722;1</sup>)</td><td align="left" valign="top" rowspan="1" colspan="1">Bacterial first&#8208;order natural death rate constant</td><td align="left" valign="top" rowspan="1" colspan="1">0.179</td><td align="left" valign="top" rowspan="1" colspan="1">(Fixed)</td><td align="left" valign="top" rowspan="1" colspan="1">0.179</td><td align="left" valign="top" rowspan="1" colspan="1">(Fixed)</td><td align="left" valign="top" rowspan="1" colspan="1">0.179</td><td align="left" valign="top" rowspan="1" colspan="1">(Fixed)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">k<sub>lag</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1">(h<sup>&#8722;1</sup>)</td><td align="left" valign="top" rowspan="1" colspan="1">Bacterial first&#8208;order growth&#8208;lag rate constant</td><td align="left" valign="top" rowspan="1" colspan="1">0.343</td><td align="left" valign="top" rowspan="1" colspan="1">(32)</td><td align="left" valign="top" rowspan="1" colspan="1">0.420</td><td align="left" valign="top" rowspan="1" colspan="1">(43)</td><td align="left" valign="top" rowspan="1" colspan="1">0.290</td><td align="left" valign="top" rowspan="1" colspan="1">(40)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">B<sub>max</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1">(CFU/mL)</td><td align="left" valign="top" rowspan="1" colspan="1">Maximum system capacity</td><td align="left" valign="top" rowspan="1" colspan="1">2.5 &#215;&#8201;10<sup>9</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">(Fixed)</td><td align="left" valign="top" rowspan="1" colspan="1">2.5 &#215;&#8201;10<sup>9</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">(Fixed)</td><td align="left" valign="top" rowspan="1" colspan="1">2.5 &#215;&#8201;10<sup>9</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">(Fixed)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ERR<xref rid="psp413046-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
<italic toggle="yes">&#969;</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">(CFU/mL)</td><td align="left" valign="top" rowspan="1" colspan="1">Additive error term for in vitro CFU</td><td align="left" valign="top" rowspan="1" colspan="1">0.115</td><td align="left" valign="top" rowspan="1" colspan="1">(10)</td><td align="left" valign="top" rowspan="1" colspan="1">0.279</td><td align="left" valign="top" rowspan="1" colspan="1">(16)</td><td align="left" valign="top" rowspan="1" colspan="1">0.279</td><td align="left" valign="top" rowspan="1" colspan="1">(8.0)</td></tr><tr><td align="left" colspan="9" valign="top" rowspan="1">Neutrophil&#8208;mediated bacterial killing&#8212;in vitro</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">k<sub>N,max,dig</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1">(h<sup>&#8722;1</sup>)</td><td align="left" valign="top" rowspan="1" colspan="1">Neutrophil first&#8208;order maximum digestion rate constant</td><td align="left" valign="top" rowspan="1" colspan="1">5.61</td><td align="left" valign="top" rowspan="1" colspan="1">(47)</td><td align="left" rowspan="2" valign="top" colspan="1">8.85<xref rid="psp413046-note-0003" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="left" rowspan="2" valign="top" colspan="1">(14)</td><td align="left" rowspan="2" valign="top" colspan="1">8.85<xref rid="psp413046-note-0003" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="left" rowspan="2" valign="top" colspan="1">(13)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">k<sub>N,max,phag</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1">(h<sup>&#8722;1</sup>)</td><td align="left" valign="top" rowspan="1" colspan="1">Neutrophil first&#8208;order maximum phagocytosis rate constant</td><td align="left" valign="top" rowspan="1" colspan="1">8.35</td><td align="left" valign="top" rowspan="1" colspan="1">(11)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">k<sub>N,loss,dig</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1">(h<sup>&#8722;1</sup>)</td><td align="left" valign="top" rowspan="1" colspan="1">Time&#8208;related decrease in neutrophil digestion</td><td align="left" valign="top" rowspan="1" colspan="1">0.961</td><td align="left" valign="top" rowspan="1" colspan="1">(14)</td><td align="left" rowspan="2" valign="top" colspan="1">0.781<xref rid="psp413046-note-0003" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="left" rowspan="2" valign="top" colspan="1">(13)</td><td align="left" rowspan="2" valign="top" colspan="1">0.779<xref rid="psp413046-note-0003" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="left" rowspan="2" valign="top" colspan="1">(13)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">k<sub>N,loss,phag</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1">(h<sup>&#8722;1</sup>)</td><td align="left" valign="top" rowspan="1" colspan="1">Time&#8208;related decrease in neutrophil phagocytosis</td><td align="left" valign="top" rowspan="1" colspan="1">0.771</td><td align="left" valign="top" rowspan="1" colspan="1">(11)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">N<sub>50,dig</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1">(N/mL)</td><td align="left" valign="top" rowspan="1" colspan="1">Neutrophil concentration resulting in 50% of maximum digestion rate</td><td align="left" valign="top" rowspan="1" colspan="1">3.98 &#215;&#8201;10<sup>6</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">(6.2)</td><td align="left" valign="top" rowspan="1" colspan="1">6.46 &#215;&#8201;10<sup>6</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">(1.5)</td><td align="left" valign="top" rowspan="1" colspan="1">6.55 &#215;&#8201;10<sup>6</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">(1.4)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">N<sub>50,phag</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1">(N/mL)</td><td align="left" valign="top" rowspan="1" colspan="1">Neutrophil concentration resulting in 50% of maximum phagocytosis rate</td><td align="left" valign="top" rowspan="1" colspan="1">6.92 &#215;&#8201;10<sup>5</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">(5.3)</td><td align="left" valign="top" rowspan="1" colspan="1">1.46 &#215;&#8201;10<sup>6</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">(4.6)</td><td align="left" valign="top" rowspan="1" colspan="1">1.19 &#215;&#8201;10<sup>6</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">(4.3)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P/N<sub>50,dig</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1">(CFU/N)</td><td align="left" valign="top" rowspan="1" colspan="1">Phagocytosed bacteria to total neutrophil count reducing digestion rate by 50%</td><td align="left" valign="top" rowspan="1" colspan="1">2.84</td><td align="left" valign="top" rowspan="1" colspan="1">(29)</td><td align="left" rowspan="2" valign="top" colspan="1">3.32<xref rid="psp413046-note-0003" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="left" rowspan="2" valign="top" colspan="1">(21)</td><td align="left" rowspan="2" valign="top" colspan="1">3.41<xref rid="psp413046-note-0003" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="left" rowspan="2" valign="top" colspan="1">(22)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P/N<sub>50,phag</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1">(CFU/N)</td><td align="left" valign="top" rowspan="1" colspan="1">Phagocytosed bacteria to total neutrophil count reducing phagocytosis rate by 50%</td><td align="left" valign="top" rowspan="1" colspan="1">3.92</td><td align="left" valign="top" rowspan="1" colspan="1">(26)</td></tr><tr><td align="left" colspan="9" valign="top" rowspan="1">Neutrophil and cyclophosphamide PKPD&#8212;in vivo</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CL</td><td align="left" valign="top" rowspan="1" colspan="1">(mL/h)</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide clearance</td><td align="left" valign="top" rowspan="1" colspan="1">0.311</td><td align="left" valign="top" rowspan="1" colspan="1">(Scaled)</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">0.311</td><td align="left" valign="top" rowspan="1" colspan="1">(Scaled)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">V</td><td align="left" valign="top" rowspan="1" colspan="1">(mL)</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide distribution volume</td><td align="left" valign="top" rowspan="1" colspan="1">0.153</td><td align="left" valign="top" rowspan="1" colspan="1">(Scaled)</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">0.153</td><td align="left" valign="top" rowspan="1" colspan="1">(Scaled)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">k<sub>a</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1">(h<sup>&#8722;1</sup>)</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide first&#8208;order absorption rate constant</td><td align="left" valign="top" rowspan="1" colspan="1">20.9</td><td align="left" valign="top" rowspan="1" colspan="1">(Scaled)</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">20.9</td><td align="left" valign="top" rowspan="1" colspan="1">(Scaled)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MTT</td><td align="left" valign="top" rowspan="1" colspan="1">(h)</td><td align="left" valign="top" rowspan="1" colspan="1">Mean transit time for neutrophil bone&#8208;marrow maturation</td><td align="left" valign="top" rowspan="1" colspan="1">37.7</td><td align="left" valign="top" rowspan="1" colspan="1">(Scaled)</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">37.7</td><td align="left" valign="top" rowspan="1" colspan="1">(Scaled)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">&#947;</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">(&#8722;)</td><td align="left" valign="top" rowspan="1" colspan="1">Feedback on neutrophil progenitor cells replication to increase/decrease output</td><td align="left" valign="top" rowspan="1" colspan="1">0.149</td><td align="left" valign="top" rowspan="1" colspan="1">(Fixed)</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">0.149</td><td align="left" valign="top" rowspan="1" colspan="1">(Fixed)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">D<sub>SLP</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1">(mL/mg)</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide linear concentration effect on neutrophil progenitor cells</td><td align="left" valign="top" rowspan="1" colspan="1">1.48</td><td align="left" valign="top" rowspan="1" colspan="1">(13)</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">1.26</td><td align="left" valign="top" rowspan="1" colspan="1">(11)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">N<sub>circ,T0</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1">(N/mL)</td><td align="left" valign="top" rowspan="1" colspan="1">Baseline circulating neutrophil count</td><td align="left" valign="top" rowspan="1" colspan="1">2.09 &#215;&#8201;10<sup>6</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">(1.5)</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">1.69 &#215;&#8201;10<sup>6</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">(0.7)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">N<sub>AMP</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1">(&#8722;)</td><td align="left" valign="top" rowspan="1" colspan="1">Surge amplitude/peak describing postinoculation influx of neutrophils into lungs</td><td align="left" valign="top" rowspan="1" colspan="1">52.2</td><td align="left" valign="top" rowspan="1" colspan="1">(17)</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">44.2</td><td align="left" valign="top" rowspan="1" colspan="1">(24)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">N<sub>T0</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1">(h)</td><td align="left" valign="top" rowspan="1" colspan="1">Parameter governing the surge peak time</td><td align="left" valign="top" rowspan="1" colspan="1">50.7</td><td align="left" valign="top" rowspan="1" colspan="1">(3.3)</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">50.5</td><td align="left" valign="top" rowspan="1" colspan="1">(3.0)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">N<sub>SW</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1">(h)</td><td align="left" valign="top" rowspan="1" colspan="1">Parameter governing the surge width</td><td align="left" valign="top" rowspan="1" colspan="1">27.1</td><td align="left" valign="top" rowspan="1" colspan="1">(11)</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">28.2</td><td align="left" valign="top" rowspan="1" colspan="1">(14)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ERR<xref rid="psp413046-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
<italic toggle="yes">&#969;</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">(N/mL)</td><td align="left" valign="top" rowspan="1" colspan="1">Additive error term for in vivo neutrophils</td><td align="left" valign="top" rowspan="1" colspan="1">0.151</td><td align="left" valign="top" rowspan="1" colspan="1">(13)</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">0.161</td><td align="left" valign="top" rowspan="1" colspan="1">(10)</td></tr><tr><td align="left" colspan="9" valign="top" rowspan="1">Bacterial dynamics and neutrophil&#8208;mediated bacterial killing&#8212;in vivo</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">k<sub>growth</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1">(h<sup>&#8722;1</sup>)</td><td align="left" valign="top" rowspan="1" colspan="1">Bacterial first&#8208;order growth rate constant</td><td align="left" valign="top" rowspan="1" colspan="1">0.489</td><td align="left" valign="top" rowspan="1" colspan="1">(7.7)</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">0.502</td><td align="left" valign="top" rowspan="1" colspan="1">(18)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">k<sub>N,max</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1">(h<sup>&#8722;1</sup>)</td><td align="left" valign="top" rowspan="1" colspan="1">Neutrophil first&#8208;order maximum phagocytosis and digestion rate constant</td><td align="left" valign="top" rowspan="1" colspan="1">1.25</td><td align="left" valign="top" rowspan="1" colspan="1">(29)</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">0.820</td><td align="left" valign="top" rowspan="1" colspan="1">(33)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">k<sub>N,loss</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1">(h<sup>&#8722;1</sup>)</td><td align="left" valign="top" rowspan="1" colspan="1">Time&#8208;related decrease in neutrophil phagocytosis and digestion</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">(Fixed)</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">(Fixed)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">k<sub>M,kill</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1">(h<sup>&#8722;1</sup>)</td><td align="left" valign="top" rowspan="1" colspan="1">First&#8208;order rate constant for the additional in vivo phagocytic capacity</td><td align="left" valign="top" rowspan="1" colspan="1">0.279</td><td align="left" valign="top" rowspan="1" colspan="1">(19)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">0.287</td><td align="left" valign="top" rowspan="1" colspan="1">(18)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">k<sub>M,loss</sub>
</td><td align="left" valign="top" rowspan="1" colspan="1">(h<sup>&#8722;1</sup>)</td><td align="left" valign="top" rowspan="1" colspan="1">Time&#8208;related decrease in the additional in vivo phagocytic capacity</td><td align="left" valign="top" rowspan="1" colspan="1">0.0107</td><td align="left" valign="top" rowspan="1" colspan="1">(48)</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">0.0111</td><td align="left" valign="top" rowspan="1" colspan="1">(45)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ERR<xref rid="psp413046-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
<italic toggle="yes">&#969;</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">(CFU/g)</td><td align="left" valign="top" rowspan="1" colspan="1">Additive error term for in vivo CFU</td><td align="left" valign="top" rowspan="1" colspan="1">0.605</td><td align="left" valign="top" rowspan="1" colspan="1">(9.6)</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">0.600</td><td align="left" valign="top" rowspan="1" colspan="1">(9.4)</td></tr></tbody></table><table-wrap-foot id="psp413046-ntgp-0002"><fn id="psp413046-note-0100"><p>Abbreviation: RSE%, relative standard error in percent.</p></fn><fn id="psp413046-note-0002"><label>
<sup>a</sup>
</label><p>ERR refers to the magnitude of residual unexplained variability (on the standard deviation scale).</p></fn><fn id="psp413046-note-0003"><label>
<sup>b</sup>
</label><p>Parameters were shared between dig and phag processes.</p></fn></table-wrap-foot></table-wrap><fig position="float" fig-type="FIGURE" id="psp413046-fig-0002" orientation="portrait"><label>FIGURE 2</label><caption><p>Overview of the digitized data used to develop the model and how well simulations from the final model can replicate the digitized time courses. The points represent observations, the solid lines represent the medians of the observations, the dashed lines represent the medians of model simulations, and the shaded areas are 95% confidence intervals for the simulated medians. (a) In vitro studies, covering bacterial growth controls (without addition of neutrophils), digestion of phagocytosed bacteria, extracellular (i.e., nondigested) bacteria, and studies quantifying total bacteria (with approximate neutrophil concentration in the panel headers). (b) In vivo studies measuring neutrophil influx in lungs after administration of bacteria and circulating neutrophils with and without cyclophosphamide treatment (regimen in legend). (c) In vivo studies quantifying the growth of bacteria in the lungs of immune&#8208;competent and cyclophosphamide&#8208;treated mice. CFU, colony forming unit.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-3" orientation="portrait" xlink:href="PSP4-12-1972-g002.jpg"/></fig><fig position="float" fig-type="FIGURE" id="psp413046-fig-0003" orientation="portrait"><label>FIGURE 3</label><caption><p>(a) Model evaluation on external in vitro data<xref rid="psp413046-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> through simulations from the final model. The points represent digitized observations, the solid lines represent the medians of the observations, the dashed lines represent the medians of model simulations, and the shaded areas are 95% confidence intervals for the simulated medians, with the static neutrophil concentration indicated in the header. The lines represent an interpolation between two timepoints (0 and 1&#8201;h) and is not a model prediction of the time course. (b) Identification of the same biphasic relation between neutrophil concentration and change in bacterial burden as shown previously.<xref rid="psp413046-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> The color represents the colony forming unit [CFU] count relative to the inoculum after 1.5&#8201;h, with red indicating an increase, green indicating a decrease, and black indicating minimal&#8208;to&#8208;no change.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-5" orientation="portrait" xlink:href="PSP4-12-1972-g005.jpg"/></fig><sec id="psp413046-sec-0014"><title>Bacterial growth</title><p>Application of the bacterial model described by Equations&#160;(<xref rid="psp413046-disp-0001" ref-type="disp-formula">(1)</xref>, <xref rid="psp413046-disp-0002" ref-type="disp-formula">(2)</xref>, <xref rid="psp413046-disp-0003" ref-type="disp-formula">(3)</xref>) characterized bacterial dynamics with a k<sub>lag</sub> of 0.290&#8201;h<sup>&#8722;1</sup> (<italic toggle="yes">t</italic>
<sub>&#189;</sub> of 2.39&#8201;h) and a k<sub>growth</sub> of 1.84&#8201;h<sup>&#8722;1</sup> (in vitro doubling time of 0.377&#8201;h). Without the lag phase a worse fit (&#916;OFV&#8201;=&#8201;+14.4) was observed and k<sub>growth</sub> reduced to 0.751&#8201;h<sup>&#8722;1</sup>.</p></sec><sec id="psp413046-sec-0015"><title>Neutrophil in vitro phagocytosis and digestion</title><p>Digestion was described as a first&#8208;order process (k<sub>N,dig</sub>) with a maximum (k<sub>N,max,dig</sub>) of 5.61&#8201;h<sup>&#8722;1</sup> (<italic toggle="yes">t</italic>
<sub>&#189;</sub> of 0.124&#8201;h), N<sub>50,dig</sub> of 3.98 &#215;&#8201;10<sup>6</sup> cells/mL (&#916;OFV&#8201;=&#8201;&#8722;25.3, compared to a linear relation). Improvement was seen when accumulation of bacteria reduced k<sub>N,dig</sub>, with P/N<sub>50,dig</sub> estimated to 2.84 (&#916;OFV&#8201;=&#8201;&#8722;27.9). Lastly, an exponential time&#8208;driven decrease in k<sub>N,dig</sub> further improved the fit (&#916;OFV&#8201;=&#8201;&#8722;23.7), with a k<sub>N,loss,dig</sub> of 0.961&#8201;h<sup>&#8722;1</sup> (<italic toggle="yes">t</italic>
<sub>&#189;</sub> of 0.721&#8201;h). Phagocytosis (k<sub>N,phag</sub>) was described similarly: k<sub>N,max,phag</sub> of 8.35&#8201;h<sup>&#8722;1</sup> (<italic toggle="yes">t</italic>
<sub>&#189;</sub> of 0.0830&#8201;h), N<sub>50,phag</sub> of 6.92 &#215;&#8201;10<sup>5</sup> cells/mL (&#916;OFV&#8201;=&#8201;&#8722;133), P/N<sub>50,phag</sub> of 3.92 (&#916;OFV&#8201;=&#8201;&#8722;151), and a k<sub>N,loss,phag</sub> of 0.771&#8201;h<sup>&#8722;1</sup> (<italic toggle="yes">t</italic>
<sub>&#189;</sub> of 0.899&#8201;h) (&#916;OFV&#8201;=&#8201;&#8722;81.9).</p><p>Simplifications were evaluated by allowing shared parameters for digestion and phagocytosis (e.g., one k<sub>N,max</sub> for both processes). Six parameters could be reduced to three (shared k<sub>N,max</sub> [&#916;OFV&#8201;=&#8201;+0.033], k<sub>N,loss</sub> [&#916;OFV&#8201;=&#8201;+0.837], and P/N<sub>50</sub> [&#916;OFV&#8201;=&#8201;+0.95], with total &#916;OFV&#8201;=&#8201;+2.12), whereas separate N<sub>50,dig</sub> and N<sub>50,phag</sub> were kept (&#916;OFV&#8201;=&#8201;+6.15).</p></sec><sec id="psp413046-sec-0016"><title>Neutrophil in vivo dynamics and bacterial killing</title><p>Neutrophil data were adequately described by the chosen structural model, when the slope for cyclophosphamide&#8208;induced killing of proliferating cells (D<sub>SLP</sub> of 1.26&#8201;mL/mg) and neutrophil baseline N<sub>circ,T0</sub> (1.69 &#215;&#8201;10<sup>6</sup> cells/mL) were estimated from the data. The rate of neutrophil influx into the lung peaked approximately 2&#8201;days after infection (N<sub>T0</sub> of 50.5&#8201;h) with a large increase (<italic toggle="yes">N</italic>
<sub>AMP</sub> of 44.2) and with a wide peak duration (N<sub>SW</sub> of 28.2&#8201;h). Reduced bacterial growth and maximum neutrophil activity (k<sub>growth</sub> of 0.502&#8201;h<sup>&#8722;1</sup> and k<sub>N,max</sub> of 0.820&#8201;h<sup>&#8722;1</sup>, &#916;OFV&#8201;=&#8201;&#8722;188), and an additional phagocytic capacity was found in vivo (k<sub>M,kill</sub> of 0.287&#8201;h<sup>&#8722;1</sup>, &#916;OFV&#8201;=&#8201;&#8722;23.5). Although no links could be established between k<sub>M,kill</sub> and the alveolar macrophage time course, a cyclophosphamide&#8208;related reduction in k<sub>M,kill</sub> (proportional to N<sub>circ</sub>/N<sub>circ,T0</sub>, &#916;OFV&#8201;=&#8201;&#8722;16.9) and a time&#8208;driven reduction (k<sub>M,loss</sub> of 0.0111&#8201;h<sup>&#8722;1</sup>, &#916;OFV&#8201;=&#8201;&#8722;5.51) were identified.</p></sec><sec id="psp413046-sec-0017"><title>Model predictions</title><p>The predicted neutrophil time course in blood and lungs of patients receiving cyclophosphamide according to three different regimens are shown in Figure&#160;<xref rid="psp413046-fig-0004" ref-type="fig">4</xref>. The predictions illustrate how increased doses of cyclophosphamide impacts circulating and lung influx of neutrophils (reduced peak with CFU inoculation at 5&#8201;weeks). The predicted bacterial time course is shown in Figure&#160;<xref rid="psp413046-fig-0005" ref-type="fig">5</xref>, indicating that untreated individuals are predicted to be able to eradicate the bacteria completely across burdens, although the time of eradication is delayed at higher burdens. More than 50% of patients treated with 10&#8201;mg/kg q1w and 20&#8201;mg/kg q10d regimens are predicted to handle lower bacterial burdens (10<sup>6</sup> and 10<sup>7</sup>&#8201;CFU/g lung), but the typical patient fails to eradicate burdens &#8805;10<sup>8</sup>&#8201;CFU/g lung, whereas patients treated with a supratherapeutic dose of 60&#8201;mg/kg q3w dose fails to combat bacteria at any burden.</p><fig position="float" fig-type="FIGURE" id="psp413046-fig-0004" orientation="portrait"><label>FIGURE 4</label><caption><p>Prediction of neutrophil time courses in blood (top) and lung (bottom) for <italic toggle="yes">n</italic>&#8201;=&#8201;1000 individuals (70&#8201;kg) treated with cyclophosphamide as indicated in the header (three regimens plus control). Bacteria is deposited in the lungs at 5&#8201;weeks (indicated by arrows), which is associated with the surge in lung neutrophil concentration. The red solid lines represent the medians and the dashed red lines the 5th and 95th percentiles of the predictions. The horizonal dashed lines in the top panel indicates the cutoff for Grade 4 (Gr4) neutropenia. q10d, every 10&#8201;days; q1w, every week; q3w, every third week.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-7" orientation="portrait" xlink:href="PSP4-12-1972-g004.jpg"/></fig><fig position="float" fig-type="FIGURE" id="psp413046-fig-0005" orientation="portrait"><label>FIGURE 5</label><caption><p>Prediction of bacterial time courses in lung for <italic toggle="yes">n</italic>&#8201;=&#8201;1000 individuals (70&#8201;kg) treated with cyclophosphamide as indicated in the header (three regimens plus control). Neutrophil time courses are as shown in Figure&#160;<xref rid="psp413046-fig-0004" ref-type="fig">4</xref>, with bacteria deposited in the lungs at 5&#8201;weeks. The red solid lines represent the medians and the dashed red lines the 5th and 95th percentiles of the predictions. CFU, colony forming unit; q10d, every 10&#8201;days; q1w, every week; q3w, every third week.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-9" orientation="portrait" xlink:href="PSP4-12-1972-g003.jpg"/></fig></sec></sec><sec sec-type="discussion" id="psp413046-sec-0018"><title>DISCUSSION</title><p>This work describes the development of a mathematical model (Figure&#160;<xref rid="psp413046-fig-0001" ref-type="fig">1</xref>) that is able to predict neutrophil&#8208;mediated killing of bacteria across in vitro and in vivo experiments through two separate processes that represent phagocytosis and digestion. The model builds on a previously developed framework for assessment of bacterial dynamics and antibiotic&#8208;induced bacterial killing by linking bacterial concentration to static (in vitro) or dynamic (in vivo) neutrophil concentrations.<xref rid="psp413046-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref> The dynamic neutrophil counts relied on an established model, which has been shown to scale adequately between animals and humans.<xref rid="psp413046-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref>, <xref rid="psp413046-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref> The model's ability to replicate the various designs of the underlying data is evident in Figure&#160;<xref rid="psp413046-fig-0002" ref-type="fig">2</xref>, whereas external evaluation of the in vitro model (Figure&#160;<xref rid="psp413046-fig-0003" ref-type="fig">3</xref>) was found to slightly underpredict the observed killing. This may reflect a lower maximum system capacity (B<sub>max</sub>) in the external data, possibly related to in vitro experimental variability caused by differences in the type of bacteria (clinical isolates vs. reference strains), immune cells (granulocytes vs. neutrophils), or in the experimental set&#8208;up. The model did, however, display the same biphasic pattern in CFU change across different bacterial inoculum and neutrophil concentrations, where a neutrophil concentration of 0.5 &#215;&#8201;10<sup>6</sup> cell/mL is enough to deal with bacterial inoculums up to 10<sup>6</sup>&#8201;CFU/mL, but where progressively higher neutrophil concentrations are required with bacterial inoculums above 10<sup>6</sup>&#8201;CFU/mL.<xref rid="psp413046-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>
</p><p>A potency estimate related to neutrophil&#8208;mediated killing of 1.91 &#215;&#8201;10<sup>5</sup> cells/mL has been reported, which is lower than our final estimates of 1.19 &#215;&#8201;10<sup>6</sup> cell/mL for phagocytosis and 6.55 &#215;&#8201;10<sup>6</sup> cell/mL for digestion.<xref rid="psp413046-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref> However, the previous model, which was based on a single study, did not separate phagocytosis and digestion processes or consider the effect of an increasing P/N ratio. Moreover, the study did not use time&#8208;varying lung neutrophil concentration (but the circulating count), which may result in a lower estimate. The separation between phagocytosis and digestion was partly informed by intracellular digestion studies<xref rid="psp413046-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>, <xref rid="psp413046-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref> and nondigested studies.<xref rid="psp413046-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>, <xref rid="psp413046-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref>, <xref rid="psp413046-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref> As the estimate of N<sub>50,dig</sub> was higher than for N<sub>50,phag</sub> (the fit was significantly worse with a shared parameter), the digestion process became rate&#8208;limiting for removal of bacteria.<xref rid="psp413046-bib-0036" ref-type="bibr">
<sup>36</sup>
</xref> Although the digestion rate would not intuitively depend on the system neutrophil concentration, it may be explained by improved cell&#8211;cell interaction and a more even distribution of phagocytosed bacteria across neutrophils at higher neutrophil concentrations.<xref rid="psp413046-bib-0043" ref-type="bibr">
<sup>43</sup>
</xref>
</p><p>The link between the phagocytosis and digestion rates and the P/N ratio may be explained partly through an increased release of antimicrobial peptides, an increased concentration of toxic bacterial products, and an increased stress on the neutrophil cell structure, which compromises the integrity of the neutrophil. An approximate neutrophil capacity of 50&#8201;CFU per cell has been reported,<xref rid="psp413046-bib-0044" ref-type="bibr">
<sup>44</sup>
</xref> which under the model (P/N<sub>50</sub>) estimation would result in a 94% reduction of k<sub>phag</sub> and k<sub>dig</sub>, irrespective of the neutrophil concentration. A time&#8208;dependent decrease of the phagocytosis and digestion rates (k<sub>N,loss</sub>) accounted for progressive in vitro system fatigue, explained by a loss of opsonization and neutrophil deterioration, which may also affect phagosome maturation (important for digestion).<xref rid="psp413046-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>, <xref rid="psp413046-bib-0037" ref-type="bibr">
<sup>37</sup>
</xref> The in vitro model development did not account for additional bacterial elimination mechanisms, such as extracellular elimination by reactive chemical molecules or extracellular traps.<xref rid="psp413046-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>, <xref rid="psp413046-bib-0045" ref-type="bibr">
<sup>45</sup>
</xref>
</p><p>For the in vivo neutrophil dynamics, a postinoculation surge in lung neutrophils was achieved by linking the circulating neutrophil compartment to a compartment representing lungs. Prior to inoculation, the concentration of lung neutrophils (cells/lung) was approximately equal to that in blood (cells/mL), when accounting for lung weight (0.175&#8201;g) and/or lung blood volume (0.177&#8201;mL).<xref rid="psp413046-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref>, <xref rid="psp413046-bib-0046" ref-type="bibr">
<sup>46</sup>
</xref> At the peak influx, occurring approximately 2&#8201;days postinoculation, the neutrophil lung concentration exceeded 6.31 &#215;&#8201;10<sup>7</sup> cells/g lung, more than 30&#215; the circulating concentration. This reaffirms, that the immune response is designed to hit hard and strong, to eradicate pathogens swiftly. However, although the data contained sufficient information to describe neutrophil lung influx, it did not allow for a mechanistic description of the neutrophil source (i.e., bone&#8208;marrow reserves, marginated pool) or for inoculum&#8208;related differences in influx or increase in circulating counts as infection occurred.<xref rid="psp413046-bib-0047" ref-type="bibr">
<sup>47</sup>
</xref> New studies could examine these dynamics further, which would help to determine the extent of the immune system's ability to fight an infection, before neutrophil reserves are exhausted. In the model, the estimate of N<sub>SW</sub> sustains the neutrophil influx, and all immune&#8208;competent mice could eliminate the infection up to the highest inoculum of 5.71 &#215;&#8201;10<sup>8</sup>&#8201;CFU/g lung (Figure&#160;<xref rid="psp413046-fig-0002" ref-type="fig">2</xref>). The cyclophosphamide&#8208;driven reduction in circulating neutrophils resulted in a lower lung influx, which is sensible as the myelosuppressive therapy is expected to affect neutrophil (and phagocytic) reserves across tissues, with a similar effect on the additional in vivo phagocytic capacity (~5&#8208;fold reduction). The estimated D<sub>SLP</sub> of 1.26&#8201;mL/mg (neutrophils) was lower than the 2.65&#8201;mL/mg (total leukocytes) estimated in rats, even though neutrophils are expected to be more sensitive to cyclophosphamide than total leukocytes.<xref rid="psp413046-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref> However, given the limited information (no time course) and lack of data on key aspects such as species differences in protein binding and in susceptibility, the re&#8208;estimation of D<sub>SLP</sub> was considered an acceptable option.<xref rid="psp413046-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref>
</p><p>The identified parameter differences in vivo were: (i) a 73% reduced growth rate (k<sub>growth</sub> of 0.502&#8201;h<sup>&#8722;1</sup>, doubling time of 1.38&#8201;h), explained by less optimal in vivo growth conditions,<xref rid="psp413046-bib-0048" ref-type="bibr">
<sup>48</sup>
</xref> (ii) a 91% decreased maximum neutrophil kill rate (k<sub>N,max</sub> of 0.820&#8201;h<sup>&#8722;1</sup>, <italic toggle="yes">t</italic>
<sub>&#189;</sub> of 0.845&#8201;h), which may be explained by a more restricted access of neutrophils to engage with bacteria (not a well&#8208;mixed solution, as in vitro), and (iii) removal of the time&#8208;driven decrease in activity (k<sub>N,loss</sub> of 0, as a constant outflow of cells was implemented in the in vivo model). An additional in vivo capacity for phagocytosis was identified, potentially representing lung alveolar macrophages. Although alveolar macrophages are the primary phagocytic cell at baseline conditions they only modestly increase following deposition of bacteria, whereas neutrophils greatly increase in numbers and rapidly make up the majority of phagocytic cells present in lung.<xref rid="psp413046-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref>, <xref rid="psp413046-bib-0049" ref-type="bibr">
<sup>49</sup>
</xref> The additional phagocytic capacity (k<sub>M,kill</sub> of 0.287&#8201;h<sup>&#8722;1</sup>) resulted in initial bacterial elimination with half&#8208;lives of 2.42&#8201;h and ~12.1&#8201;h in immune&#8208;competent and compromised mice, respectively, but reduced over time (<italic toggle="yes">t</italic>
<sub>&#189;</sub> of 62&#8201;h) following imitation of the infection. Although the decrease could partly be ascribed to a low influx of new macrophages to the infected tissues (relative to influx of neutrophils), it might also partly reflect the role that macrophages play in phagocytosis of apoptotic and nonapoptotic neutrophils (i.e., phagocytosed instead of bacteria).<xref rid="psp413046-bib-0050" ref-type="bibr">
<sup>50</sup>
</xref>
</p><p>Simplifications were made in the description of bacterial dynamics due to the sparse data informing k<sub>growth</sub> and B<sub>max</sub>, and the in vitro estimate of k<sub>growth</sub> covers multiple bacterial species and different studies. The estimate of k<sub>growth</sub> is comparable to previous estimates of 1.35&#8201;h<sup>&#8722;1</sup> for <italic toggle="yes">Streptococcus pyogenes</italic>,<xref rid="psp413046-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref> 1.56&#8201;h<sup>&#8722;1</sup> for <italic toggle="yes">S. aureus</italic>, and 1.45 for <italic toggle="yes">E. coli</italic>,<xref rid="psp413046-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> whereas the system capacity was fixed to the upper limit of the digitized data. The impact of fixing k<sub>death</sub> to the value from the original publication (0.179&#8201;h<sup>&#8722;1</sup>) was judged to be minor, as any difference in k<sub>death</sub> would be compensated for in the k<sub>growth</sub> estimate because those parameters are correlated. Moreover, the data did not support the estimation of k<sub>RS</sub>, and it was therefore assumed that the bacteria in the resting state would not transfer back to the growing state given the continuous high stress in the environment and the short time frame of the experiments. Similarly, the underlying data did not allow the estimation of differences in neutrophil&#8208;mediated killing for different bacterial species. Although this is rational for the in vitro studies (as a result of well&#8208;stirred conditions and proximity between neutrophils and bacteria), the in vivo studies focused on a single species (<italic toggle="yes">A. baumannii</italic>) because of the large between&#8208;pathogen variability in stimulation of the innate host response. However, although the model is a general description of neutrophil&#8208;mediated bacterial killing, it can readily be expanded with new data and covariate effects such as those describing species differences in growth or kill. Further mouse studies (and modeling efforts) should explore differences in host response and phagocytic capacity toward different bacterial species at different inoculums.</p><p>Predictions of human neutrophil and bacterial dynamics (Figures&#160;<xref rid="psp413046-fig-0003" ref-type="fig">3</xref>, <xref rid="psp413046-fig-0004" ref-type="fig">4</xref>, <xref rid="psp413046-fig-0005" ref-type="fig">5</xref>) indicate that a fixed neutrophil concentration at which all pathogens are successfully eliminated is difficult to derive. Instead, whether a given bacterial inoculum will result in manifestation of eradication depends on the bacterial burden in relation to the neutrophil concentration. In addition, the &#8220;critical neutrophil concentration&#8221; (0.3&#8211;0.5 &#215;&#8201;10<sup>6</sup> cell/mL) is comparable to Grade 4 neutropenia (Figures&#160;<xref rid="psp413046-fig-0003" ref-type="fig">3</xref> and <xref rid="psp413046-fig-0005" ref-type="fig">5</xref>), below which the neutrophil number is insufficient to handle even the mildest infections.<xref rid="psp413046-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref>, <xref rid="psp413046-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref> From Figure&#160;<xref rid="psp413046-fig-0005" ref-type="fig">5</xref> (moderate and high dose), it appears that individuals who reach Grade 4 neutropenia (circulating counts) will have difficulties to eradicate the lower burdens of 10<sup>6</sup> and 10<sup>7</sup>&#8201;CFU/g lung. Indeed, irrespective of patients having neutrophil concentrations above the Grade 4 cutoff, any myelosuppressive drug&#8208;induced reduction in neutrophils prevents individuals from dealing with the higher burdens of 10<sup>8</sup> and 10<sup>9</sup>&#8201;CFU/g lung, whereas untreated subjects are still predicted to eradicate such burdens. However, as these results are extrapolated from mice, clinical data informing the temporal aspects of neutrophil concentration, bacterial burden, and host&#8208;response biomarkers (cytokines, chemokines) would help to further elucidate the interindividual variability in host&#8208;response mechanisms and phagocytic capacity. The presented model suggests that effective phagocytosis does not only depend on neutrophil concentration, but on the bacterial growth (and natural death) rates and the bacteria&#8208;to&#8208;neutrophil ratio. As example calculations, the &#8220;critical neutrophil concentration&#8221; range would result in initial (i.e., phagocytosis at time zero) bacterial <italic toggle="yes">t</italic>
<sub>&#189;</sub>'s of 5.73 and 0.724&#8201;h in vitro and 5.72 and 3.49&#8201;h in vivo, respectively.</p><p>In conclusion, we established a model&#8208;based description of neutrophil&#8208;mediated killing of bacteria through processes of phagocytosis and digestion across in vitro and in vivo studies. The model was used to predict neutrophil&#8208;bacterial time courses in patients treated with cyclophosphamide and may be used in the exploration of antibiotic dosing regimens to assess or compare host&#8208;response and antibiotic drug effects.</p></sec><sec id="psp413046-sec-0019"><title>AUTHOR CONTRIBUTIONS</title><p>A.T., A.D.P., L.E.F., and E.I.N. wrote the manuscript. A.T., A.D.P., L.E.F., and E.I.N. designed the research. A.T. and A.D.P. performed the research. A.T., A.D.P., L.E.F., and E.I.N. analyzed the data.</p></sec><sec id="psp413046-sec-0021"><title>FUNDING INFORMATION</title><p>The scientific work was supported by The Swedish Cancer Society (CAN 2017/626) and by The Swedish Research Council (VR 2018&#8208;03296), and computational resources were funded by The Swedish Research Council (VR 2018&#8208;05973).</p></sec><sec sec-type="COI-statement" id="psp413046-sec-0020"><title>CONFLICT OF INTEREST statement</title><p>The authors declared no competing interests for this work.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="psp413046-supitem-0001" position="float" content-type="local-data" orientation="portrait"><caption><p>
Data S1
</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="PSP4-12-1972-s001.csv" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="psp413046-supitem-0002" position="float" content-type="local-data" orientation="portrait"><caption><p>
Data S2
</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="PSP4-12-1972-s002.docx" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ref-list content-type="cited-references" id="psp413046-bibl-0001"><title>REFERENCES</title><ref id="psp413046-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="psp413046-cit-0001"><string-name name-style="western"><surname>Rosales</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Lowell</surname><given-names>CA</given-names></string-name>, <string-name name-style="western"><surname>Schnoor</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Uribe&#8208;Querol</surname><given-names>E</given-names></string-name>. <article-title>Neutrophils: their role in innate and adaptive immunity 2017</article-title>. <source>J Immunol Res</source>. <year>2017</year>;<volume>2017</volume>:<fpage>1</fpage>&#8208;<lpage>2</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2017/9748345</pub-id><pub-id pub-id-type="pmcid">PMC5697120</pub-id><pub-id pub-id-type="pmid">29238732</pub-id></mixed-citation></ref><ref id="psp413046-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="psp413046-cit-0002"><string-name name-style="western"><surname>Summers</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Rankin</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Condliffe</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Singh</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Peters</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Chilvers</surname><given-names>ER</given-names></string-name>. <article-title>Neutrophil kinetics in health and disease</article-title>. <source>Trends Immunol</source>. <year>2010</year>;<volume>31</volume>:<fpage>318</fpage>&#8208;<lpage>324</lpage>.<pub-id pub-id-type="pmid">20620114</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.it.2010.05.006</pub-id><pub-id pub-id-type="pmcid">PMC2930213</pub-id></mixed-citation></ref><ref id="psp413046-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="psp413046-cit-0003"><string-name name-style="western"><surname>Hidalgo</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Chilvers</surname><given-names>ER</given-names></string-name>, <string-name name-style="western"><surname>Summers</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Koenderman</surname><given-names>L</given-names></string-name>. <article-title>The neutrophil life cycle</article-title>. <source>Trends Immunol</source>. <year>2019</year>;<volume>40</volume>:<fpage>584</fpage>&#8208;<lpage>597</lpage>.<pub-id pub-id-type="pmid">31153737</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.it.2019.04.013</pub-id></mixed-citation></ref><ref id="psp413046-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="psp413046-cit-0004"><string-name name-style="western"><surname>Neth</surname><given-names>OW</given-names></string-name>, <string-name name-style="western"><surname>Bajaj&#8208;Elliott</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Turner</surname><given-names>MW</given-names></string-name>, <string-name name-style="western"><surname>Klein</surname><given-names>NJ</given-names></string-name>. <article-title>Susceptibility to infection in patients with neutropenia: the role of the innate immune system</article-title>. <source>Br J Haematol</source>. <year>2005</year>;<volume>129</volume>:<fpage>713</fpage>&#8208;<lpage>722</lpage>.<pub-id pub-id-type="pmid">15952996</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1365-2141.2005.05462.x</pub-id></mixed-citation></ref><ref id="psp413046-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="psp413046-cit-0005"><string-name name-style="western"><surname>Zimmer</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Freifeld</surname><given-names>AG</given-names></string-name>. <article-title>Optimal management of neutropenic fever in patients with cancer</article-title>. <source>J Oncol Pract</source>. <year>2019</year>;<volume>15</volume>:<fpage>19</fpage>&#8208;<lpage>24</lpage>.<pub-id pub-id-type="pmid">30629902</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/JOP.18.00269</pub-id></mixed-citation></ref><ref id="psp413046-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="psp413046-cit-0006"><string-name name-style="western"><surname>Nesher</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Rolston</surname><given-names>KVI</given-names></string-name>. <article-title>The current spectrum of infection in cancer patients with chemotherapy related neutropenia</article-title>. <source>Infection</source>. <year>2014</year>;<volume>42</volume>:<fpage>5</fpage>&#8208;<lpage>13</lpage>.<pub-id pub-id-type="pmid">23975584</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s15010-013-0525-9</pub-id></mixed-citation></ref><ref id="psp413046-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="psp413046-cit-0007"><string-name name-style="western"><surname>Maarbjerg</surname><given-names>SF</given-names></string-name>, <string-name name-style="western"><surname>Kiefer</surname><given-names>Lv</given-names></string-name>, <string-name name-style="western"><surname>Albertsen</surname><given-names>BK</given-names></string-name>, <string-name name-style="western"><surname>Schr&#248;der</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>M</given-names></string-name>. <article-title>Bloodstream infections in children with cancer: pathogen distribution and antimicrobial susceptibility patterns over a 10&#8208;year period</article-title>. <source>J Pediatr Hematol Oncol</source>. <year>2022</year>;<volume>44</volume>:<fpage>e160</fpage>&#8208;<lpage>e167</lpage>.<pub-id pub-id-type="pmid">34310474</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MPH.0000000000002258</pub-id></mixed-citation></ref><ref id="psp413046-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="psp413046-cit-0008"><string-name name-style="western"><surname>van Kessel</surname><given-names>KPM</given-names></string-name>, <string-name name-style="western"><surname>Bestebroer</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>van Strijp</surname><given-names>JAG</given-names></string-name>. <article-title>Neutrophil&#8208;mediated phagocytosis of <italic toggle="yes">Staphylococcus aureus</italic>
</article-title>. <source>Front Immunol</source>. <year>2014</year>;<volume>5</volume>:<fpage>467</fpage>.<pub-id pub-id-type="pmid">25309547</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2014.00467</pub-id><pub-id pub-id-type="pmcid">PMC4176147</pub-id></mixed-citation></ref><ref id="psp413046-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="psp413046-cit-0009"><string-name name-style="western"><surname>Dunkelberger</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Song</surname><given-names>W&#8208;C</given-names></string-name>. <article-title>Complement and its role in innate and adaptive immune responses</article-title>. <source>Cell Res</source>. <year>2010</year>;<volume>20</volume>:<fpage>34</fpage>&#8208;<lpage>50</lpage>.<pub-id pub-id-type="pmid">20010915</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/cr.2009.139</pub-id></mixed-citation></ref><ref id="psp413046-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="psp413046-cit-0010"><string-name name-style="western"><surname>Vidarsson</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Dekkers</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Rispens</surname><given-names>T</given-names></string-name>. <article-title>IgG subclasses and allotypes: from structure to effector functions</article-title>. <source>Front Immunol</source>. <year>2014</year>;<volume>5</volume>:<fpage>520</fpage>.<pub-id pub-id-type="pmid">25368619</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2014.00520</pub-id><pub-id pub-id-type="pmcid">PMC4202688</pub-id></mixed-citation></ref><ref id="psp413046-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="psp413046-cit-0011"><string-name name-style="western"><surname>Segal</surname><given-names>AW</given-names></string-name>. <article-title>How neutrophils kill microbes</article-title>. <source>Annu Rev Immunol</source>. <year>2005</year>;<volume>23</volume>:<fpage>197</fpage>&#8208;<lpage>223</lpage>.<pub-id pub-id-type="pmid">15771570</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1146/annurev.immunol.23.021704.115653</pub-id><pub-id pub-id-type="pmcid">PMC2092448</pub-id></mixed-citation></ref><ref id="psp413046-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="psp413046-cit-0012"><string-name name-style="western"><surname>Barreto</surname><given-names>JN</given-names></string-name>, <string-name name-style="western"><surname>McCullough</surname><given-names>KB</given-names></string-name>, <string-name name-style="western"><surname>Ice</surname><given-names>LL</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>JA</given-names></string-name>. <article-title>Antineoplastic agents and the associated myelosuppressive effects</article-title>. <source>J Pharm Pract</source>. <year>2014</year>;<volume>27</volume>:<fpage>440</fpage>&#8208;<lpage>446</lpage>.<pub-id pub-id-type="pmid">25147158</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0897190014546108</pub-id></mixed-citation></ref><ref id="psp413046-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="psp413046-cit-0013"><string-name name-style="western"><surname>Friberg</surname><given-names>LE</given-names></string-name>, <string-name name-style="western"><surname>Henningsson</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Maas</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Nguyen</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Karlsson</surname><given-names>MO</given-names></string-name>. <article-title>Model of chemotherapy&#8208;induced myelosuppression with parameter consistency across drugs</article-title>. <source>J Clin Oncol</source>. <year>2002</year>;<volume>20</volume>:<fpage>4713</fpage>&#8208;<lpage>4721</lpage>.<pub-id pub-id-type="pmid">12488418</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/JCO.2002.02.140</pub-id></mixed-citation></ref><ref id="psp413046-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="psp413046-cit-0014"><string-name name-style="western"><surname>Maxwell</surname><given-names>MB</given-names></string-name>, <string-name name-style="western"><surname>Maher</surname><given-names>KE</given-names></string-name>. <article-title>Chemotherapy&#8208;induced myelosuppression</article-title>. <source>Semin Oncol Nurs</source>. <year>1992</year>;<volume>8</volume>:<fpage>113</fpage>&#8208;<lpage>123</lpage>.<pub-id pub-id-type="pmid">1621002</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0749-2081(92)90027-z</pub-id></mixed-citation></ref><ref id="psp413046-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="psp413046-cit-0015"><string-name name-style="western"><surname>Abdelraouf</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Nicolau</surname><given-names>DP</given-names></string-name>. <article-title>Comparative in vivo efficacies of tedizolid in neutropenic versus immunocompetent murine <italic toggle="yes">Streptococcus pneumoniae</italic> lung infection models</article-title>. <source>Antimicrob Agents Chemother</source>. <year>2017</year>;<volume>61</volume>:<elocation-id>e01957&#8208;16</elocation-id>.<pub-id pub-id-type="pmid">27799200</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/AAC.01957-16</pub-id><pub-id pub-id-type="pmcid">PMC5192146</pub-id></mixed-citation></ref><ref id="psp413046-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="psp413046-cit-0016"><string-name name-style="western"><surname>Malka</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Wolach</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Gavrieli</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Shochat</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Rom&#8208;Kedar</surname><given-names>V</given-names></string-name>. <article-title>Evidence for bistable bacteria&#8208;neutrophil interaction and its clinical implications</article-title>. <source>J Clin Invest</source>. <year>2012</year>;<volume>122</volume>:<fpage>3002</fpage>&#8208;<lpage>3011</lpage>.<pub-id pub-id-type="pmid">22820292</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1172/JCI59832</pub-id><pub-id pub-id-type="pmcid">PMC3408731</pub-id></mixed-citation></ref><ref id="psp413046-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="psp413046-cit-0017"><string-name name-style="western"><surname>Nielsen</surname><given-names>EI</given-names></string-name>, <string-name name-style="western"><surname>Friberg</surname><given-names>LE</given-names></string-name>. <article-title>Pharmacokinetic&#8208;pharmacodynamic modeling of antibacterial drugs</article-title>. <source>Pharmacol Rev</source>. <year>2013</year>;<volume>65</volume>:<fpage>1053</fpage>&#8208;<lpage>1090</lpage>.<pub-id pub-id-type="pmid">23803529</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/pr.111.005769</pub-id></mixed-citation></ref><ref id="psp413046-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="psp413046-cit-0018"><string-name name-style="western"><surname>Bulman</surname><given-names>ZP</given-names></string-name>, <string-name name-style="western"><surname>Wicha</surname><given-names>SG</given-names></string-name>, <string-name name-style="western"><surname>Nielsen</surname><given-names>EI</given-names></string-name>, et al. <article-title>Research priorities towards precision antibiotic therapy to improve patient care</article-title>. <source>Lancet Microbe</source>. <year>2022</year>;<volume>3</volume>:<fpage>e795</fpage>&#8208;<lpage>e802</lpage>.<pub-id pub-id-type="pmid">35777386</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2666-5247(22)00121-5</pub-id></mixed-citation></ref><ref id="psp413046-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="psp413046-cit-0019"><string-name name-style="western"><surname>Leijh</surname><given-names>PC</given-names></string-name>, <string-name name-style="western"><surname>van den Barselaar</surname><given-names>MT</given-names></string-name>, <string-name name-style="western"><surname>van Zwet</surname><given-names>TL</given-names></string-name>, <string-name name-style="western"><surname>Dubbeldeman&#8208;Rempt</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>van Furth</surname><given-names>R</given-names></string-name>. <article-title>Kinetics of phagocytosis of Staphylococcus aureus and Escherichia coli by human granulocytes</article-title>. <source>Immunology</source>. <year>1979</year>;<volume>37</volume>:<fpage>453</fpage>&#8208;<lpage>465</lpage>.<pub-id pub-id-type="pmid">381182</pub-id><pub-id pub-id-type="pmcid">PMC1457489</pub-id></mixed-citation></ref><ref id="psp413046-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="psp413046-cit-0020"><string-name name-style="western"><surname>Leijh</surname><given-names>PCJ</given-names></string-name>, <string-name name-style="western"><surname>van den Barselaar</surname><given-names>MT</given-names></string-name>, <string-name name-style="western"><surname>Dubbeldeman&#8208;Rempt</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>van Furth</surname><given-names>R</given-names></string-name>. <article-title>Kinetics of intracellular killing of <italic toggle="yes">Staphylococcus aureus</italic> and <italic toggle="yes">Escherichia coli</italic> by human granulocytes</article-title>. <source>Eur J Immunol</source>. <year>1980</year>;<volume>10</volume>:<fpage>750</fpage>&#8208;<lpage>757</lpage>.<pub-id pub-id-type="pmid">7000519</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/eji.1830101005</pub-id></mixed-citation></ref><ref id="psp413046-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="psp413046-cit-0021"><string-name name-style="western"><surname>H&#252;lsheger</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Stangel</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Schmidt</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Potel</surname><given-names>J</given-names></string-name>. <article-title>Determination of maximal bactericidal activity in human granulocytes</article-title>. <source>Blut</source>. <year>1985</year>;<volume>50</volume>:<fpage>169</fpage>&#8208;<lpage>178</lpage>.<pub-id pub-id-type="pmid">3919784</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/BF00320073</pub-id></mixed-citation></ref><ref id="psp413046-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="psp413046-cit-0022"><string-name name-style="western"><surname>Pem&#225;n</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Cant&#243;n</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Hern&#225;ndez</surname><given-names>MT</given-names></string-name>, <string-name name-style="western"><surname>Gobernado</surname><given-names>M</given-names></string-name>. <article-title>Intraphagocytic killing of gram&#8208;positive bacteria by ciprofloxacin</article-title>. <source>J Antimicrob Chemother</source>. <year>1994</year>;<volume>34</volume>:<fpage>965</fpage>&#8208;<lpage>974</lpage>.<pub-id pub-id-type="pmid">7730239</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jac/34.6.965</pub-id></mixed-citation></ref><ref id="psp413046-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="psp413046-cit-0023"><string-name name-style="western"><surname>Li</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Karlin</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Loike</surname><given-names>JD</given-names></string-name>, <string-name name-style="western"><surname>Silverstein</surname><given-names>SC</given-names></string-name>. <article-title>A critical concentration of neutrophils is required for effective bacterial killing in suspension</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2002</year>;<volume>99</volume>:<fpage>8289</fpage>&#8208;<lpage>8294</lpage>.<pub-id pub-id-type="pmid">12060772</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.122244799</pub-id><pub-id pub-id-type="pmcid">PMC123060</pub-id></mixed-citation></ref><ref id="psp413046-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="psp413046-cit-0024"><string-name name-style="western"><surname>Li</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Karlin</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Loike</surname><given-names>JD</given-names></string-name>, <string-name name-style="western"><surname>Silverstein</surname><given-names>SC</given-names></string-name>. <article-title>Determination of the critical concentration of neutrophils required to block bacterial growth in tissues</article-title>. <source>J Exp Med</source>. <year>2004</year>;<volume>200</volume>:<fpage>613</fpage>&#8208;<lpage>622</lpage>.<pub-id pub-id-type="pmid">15353554</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.20040725</pub-id><pub-id pub-id-type="pmcid">PMC2212745</pub-id></mixed-citation></ref><ref id="psp413046-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="psp413046-cit-0025"><string-name name-style="western"><surname>Knapp</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Wieland</surname><given-names>CW</given-names></string-name>, <string-name name-style="western"><surname>Florquin</surname><given-names>S</given-names></string-name>, et al. <article-title>Differential roles of CD14 and toll&#8208;like receptors 4 and 2 in murine Acinetobacter pneumonia</article-title>. <source>Am J Respir Crit Care Med</source>. <year>2006</year>;<volume>173</volume>:<fpage>122</fpage>&#8208;<lpage>129</lpage>.<pub-id pub-id-type="pmid">16210672</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.200505-730OC</pub-id></mixed-citation></ref><ref id="psp413046-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="psp413046-cit-0026"><string-name name-style="western"><surname>van Faassen</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>KuoLee</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Harris</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Conlan</surname><given-names>JW</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>W</given-names></string-name>. <article-title>Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice</article-title>. <source>Infect Immun</source>. <year>2007</year>;<volume>75</volume>:<fpage>5597</fpage>&#8208;<lpage>5608</lpage>.<pub-id pub-id-type="pmid">17908807</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.00762-07</pub-id><pub-id pub-id-type="pmcid">PMC2168347</pub-id></mixed-citation></ref><ref id="psp413046-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="psp413046-cit-0027"><string-name name-style="western"><surname>Guo</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Abdelraouf</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Ledesma</surname><given-names>KR</given-names></string-name>, <string-name name-style="western"><surname>Chang</surname><given-names>KT</given-names></string-name>, <string-name name-style="western"><surname>Nikolaou</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Tam</surname><given-names>VH</given-names></string-name>. <article-title>Quantitative impact of neutrophils on bacterial clearance in a murine pneumonia model</article-title>. <source>Antimicrob Agents Chemother</source>. <year>2011</year>;<volume>55</volume>:<fpage>4601</fpage>&#8208;<lpage>4605</lpage>.<pub-id pub-id-type="pmid">21807974</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/AAC.00508-11</pub-id><pub-id pub-id-type="pmcid">PMC3186951</pub-id></mixed-citation></ref><ref id="psp413046-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="psp413046-cit-0028"><string-name name-style="western"><surname>Tsuchiya</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Nakao</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Yamamoto</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Hirai</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Miyamoto</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Tsujibo</surname><given-names>H</given-names></string-name>. <article-title>NK1.1(+) cells regulate neutrophil migration in mice with Acinetobacter baumannii pneumonia</article-title>. <source>Microbiol Immunol</source>. <year>2012</year>;<volume>56</volume>:<fpage>107</fpage>&#8208;<lpage>116</lpage>.<pub-id pub-id-type="pmid">22145920</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1348-0421.2011.00402.x</pub-id></mixed-citation></ref><ref id="psp413046-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="psp413046-cit-0029"><string-name name-style="western"><surname>Casanova&#8208;Acebes</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Nicol&#225;s&#8208;&#193;vila</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>JLY</given-names></string-name>, et al. <article-title>Neutrophils instruct homeostatic and pathological states in naive tissues</article-title>. <source>J Exp Med</source>. <year>2018</year>;<volume>215</volume>:<fpage>2778</fpage>&#8208;<lpage>2795</lpage>.<pub-id pub-id-type="pmid">30282719</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.20181468</pub-id><pub-id pub-id-type="pmcid">PMC6219739</pub-id></mixed-citation></ref><ref id="psp413046-bib-0030"><label>30</label><mixed-citation publication-type="miscellaneous" id="psp413046-cit-0030"><collab collab-type="authors">Taconic B6 Physiological Data Summary</collab>
. <year>2004</year>. Available at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.taconic.com/phenotypic-data/b6-physiological-data-summary.html" ext-link-type="uri">https://www.taconic.com/phenotypic&#8208;data/b6&#8208;physiological&#8208;data&#8208;summary.html</ext-link></mixed-citation></ref><ref id="psp413046-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="psp413046-cit-0031"><string-name name-style="western"><surname>Wickham</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Averick</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Bryan</surname><given-names>J</given-names></string-name>, et al. <article-title>Welcome to the tidyverse</article-title>. <source>J Open Source Softw</source>. <year>2019</year>;<volume>4</volume>:<fpage>1686</fpage>.</mixed-citation></ref><ref id="psp413046-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="psp413046-cit-0032"><string-name name-style="western"><surname>Wang</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Hallow</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>James</surname><given-names>D</given-names></string-name>. <article-title>A tutorial on RxODE: simulating differential equation pharmacometric models in R</article-title>. <source>CPT Pharmacometrics Syst Pharmacol</source>. <year>2016</year>;<volume>5</volume>:<fpage>3</fpage>&#8208;<lpage>10</lpage>.<pub-id pub-id-type="pmid">26844010</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/psp4.12052</pub-id><pub-id pub-id-type="pmcid">PMC4728294</pub-id></mixed-citation></ref><ref id="psp413046-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="psp413046-cit-0033"><string-name name-style="western"><surname>Keizer</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Karlsson</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Hooker</surname><given-names>A</given-names></string-name>. <article-title>Modeling and simulation workbench for NONMEM: tutorial on Pirana, PsN, and Xpose</article-title>. <source>CPT Pharmacometrics Syst Pharmacol</source>. <year>2013</year>;<volume>2</volume>:<fpage>50</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/psp.2013.24</pub-id><pub-id pub-id-type="pmcid">PMC3697037</pub-id><pub-id pub-id-type="pmid">23836189</pub-id></mixed-citation></ref><ref id="psp413046-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="psp413046-cit-0034"><string-name name-style="western"><surname>Friberg</surname><given-names>LE</given-names></string-name>, <string-name name-style="western"><surname>Sandstr&#246;m</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Karlsson</surname><given-names>MO</given-names></string-name>. <article-title>Scaling the time&#8208;course of myelosuppression from rats to patients with a semi&#8208;physiological model</article-title>. <source>Invest New Drugs</source>. <year>2010</year>;<volume>28</volume>:<fpage>744</fpage>&#8208;<lpage>753</lpage>.<pub-id pub-id-type="pmid">19711011</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10637-009-9308-7</pub-id></mixed-citation></ref><ref id="psp413046-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="psp413046-cit-0035"><string-name name-style="western"><surname>Nielsen</surname><given-names>EI</given-names></string-name>, <string-name name-style="western"><surname>Viberg</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>L&#246;wdin</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Cars</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Karlsson</surname><given-names>MO</given-names></string-name>, <string-name name-style="western"><surname>Sandstr&#246;m</surname><given-names>M</given-names></string-name>. <article-title>Semimechanistic pharmacokinetic/pharmacodynamic model for assessment of activity of antibacterial agents from time&#8208;kill curve experiments</article-title>. <source>Antimicrob Agents Chemother</source>. <year>2007</year>;<volume>51</volume>:<fpage>128</fpage>&#8208;<lpage>136</lpage>.<pub-id pub-id-type="pmid">17060524</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/AAC.00604-06</pub-id><pub-id pub-id-type="pmcid">PMC1797646</pub-id></mixed-citation></ref><ref id="psp413046-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="psp413046-cit-0036"><string-name name-style="western"><surname>Clawson</surname><given-names>CC</given-names></string-name>, <string-name name-style="western"><surname>Repine</surname><given-names>JE</given-names></string-name>. <article-title>Quantitation of maximal bactericidal capability in human neutrophils</article-title>. <source>J Lab Clin Med</source>. <year>1976</year>;<volume>88</volume>:<fpage>316</fpage>&#8208;<lpage>327</lpage>.<pub-id pub-id-type="pmid">956687</pub-id></mixed-citation></ref><ref id="psp413046-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="psp413046-cit-0037"><string-name name-style="western"><surname>Pauwels</surname><given-names>A&#8208;M</given-names></string-name>, <string-name name-style="western"><surname>Trost</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Beyaert</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Hoffmann</surname><given-names>E</given-names></string-name>. <article-title>Patterns, receptors, and signals: regulation of phagosome maturation</article-title>. <source>Trends Immunol</source>. <year>2017</year>;<volume>38</volume>:<fpage>407</fpage>&#8208;<lpage>422</lpage>.<pub-id pub-id-type="pmid">28416446</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.it.2017.03.006</pub-id><pub-id pub-id-type="pmcid">PMC5455985</pub-id></mixed-citation></ref><ref id="psp413046-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="psp413046-cit-0038"><string-name name-style="western"><surname>Jonsson</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Friberg</surname><given-names>LE</given-names></string-name>, <string-name name-style="western"><surname>Karlsson</surname><given-names>MO</given-names></string-name>, et al. <article-title>Determination of drug effect on tumour cells, host animal toxicity and drug pharmacokinetics in a hollow&#8208;fibre model in rats</article-title>. <source>Cancer Chemother Pharmacol</source>. <year>2000</year>;<volume>46</volume>:<fpage>493</fpage>&#8208;<lpage>500</lpage>.<pub-id pub-id-type="pmid">11138463</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s002800000181</pub-id></mixed-citation></ref><ref id="psp413046-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="psp413046-cit-0039"><string-name name-style="western"><surname>Movat</surname><given-names>HZ</given-names></string-name>, <string-name name-style="western"><surname>Cybulsky</surname><given-names>MI</given-names></string-name>, <string-name name-style="western"><surname>Colditz</surname><given-names>IG</given-names></string-name>, <string-name name-style="western"><surname>Chan</surname><given-names>MK</given-names></string-name>, <string-name name-style="western"><surname>Dinarello</surname><given-names>CA</given-names></string-name>. <article-title>Acute inflammation in gram&#8208;negative infection: endotoxin, interleukin 1, tumor necrosis factor, and neutrophils</article-title>. <source>Fed Proc</source>. <year>1987</year>;<volume>46</volume>:<fpage>97</fpage>&#8208;<lpage>104</lpage>.<pub-id pub-id-type="pmid">3542580</pub-id></mixed-citation></ref><ref id="psp413046-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="psp413046-cit-0040"><string-name name-style="western"><surname>Bergstrand</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Hooker</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>Wallin</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Karlsson</surname><given-names>MO</given-names></string-name>. <article-title>Prediction&#8208;corrected visual predictive checks for diagnosing nonlinear mixed&#8208;effects models</article-title>. <source>AAPS J</source>. <year>2011</year>;<volume>13</volume>:<fpage>143</fpage>&#8208;<lpage>151</lpage>.<pub-id pub-id-type="pmid">21302010</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1208/s12248-011-9255-z</pub-id><pub-id pub-id-type="pmcid">PMC3085712</pub-id></mixed-citation></ref><ref id="psp413046-bib-0041"><label>41</label><mixed-citation publication-type="miscellaneous" id="psp413046-cit-0041"><collab collab-type="authors">FASS Sendoxan</collab>
. <year>2022</year>. Available at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://libguides.hb.se/c.php?g=522497%26p=3572516" ext-link-type="uri">https://libguides.hb.se/c.php?g=522497&amp;p=3572516</ext-link></mixed-citation></ref><ref id="psp413046-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="psp413046-cit-0042"><string-name name-style="western"><surname>Sandstr&#246;m</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Lindman</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Nygren</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Johansson</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Bergh</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Karlsson</surname><given-names>MO</given-names></string-name>. <article-title>Population analysis of the pharmacokinetics and the haematological toxicity of the fluorouracil&#8208;epirubicin&#8208;cyclophosphamide regimen in breast cancer patients</article-title>. <source>Cancer Chemother Pharmacol</source>. <year>2006</year>;<volume>58</volume>:<fpage>143</fpage>&#8208;<lpage>156</lpage>.<pub-id pub-id-type="pmid">16465545</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00280-005-0140-2</pub-id></mixed-citation></ref><ref id="psp413046-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="psp413046-cit-0043"><string-name name-style="western"><surname>Nguyen</surname><given-names>GT</given-names></string-name>, <string-name name-style="western"><surname>Green</surname><given-names>ER</given-names></string-name>, <string-name name-style="western"><surname>Mecsas</surname><given-names>J</given-names></string-name>. <article-title>Neutrophils to the ROScue: mechanisms of NADPH oxidase activation and bacterial resistance</article-title>. <source>Front Cell Infect Microbiol</source>. <year>2017</year>;<volume>7</volume>:<fpage>373</fpage>.<pub-id pub-id-type="pmid">28890882</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fcimb.2017.00373</pub-id><pub-id pub-id-type="pmcid">PMC5574878</pub-id></mixed-citation></ref><ref id="psp413046-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="psp413046-cit-0044"><string-name name-style="western"><surname>Palmblad</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Engstedt</surname><given-names>L</given-names></string-name>. <article-title>Activation of the bactericidal capacity of blood granulocytes. Evaluation of a new method and the effect of levamisole</article-title>. <source>Acta Pathol Microbiol Scand C</source>. <year>1979</year>;<volume>87</volume>:<fpage>357</fpage>&#8208;<lpage>364</lpage>.<pub-id pub-id-type="pmid">546035</pub-id></mixed-citation></ref><ref id="psp413046-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="psp413046-cit-0045"><string-name name-style="western"><surname>Papayannopoulos</surname><given-names>V</given-names></string-name>. <article-title>Neutrophil extracellular traps in immunity and disease</article-title>. <source>Nat Rev Immunol</source>. <year>2018</year>;<volume>18</volume>:<fpage>134</fpage>&#8208;<lpage>147</lpage>.<pub-id pub-id-type="pmid">28990587</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nri.2017.105</pub-id></mixed-citation></ref><ref id="psp413046-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="psp413046-cit-0046"><string-name name-style="western"><surname>Kaul</surname><given-names>MG</given-names></string-name>, <string-name name-style="western"><surname>Mummert</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Graeser</surname><given-names>M</given-names></string-name>, et al. <article-title>Pulmonary blood volume estimation in mice by magnetic particle imaging and magnetic resonance imaging</article-title>. <source>Sci Rep</source>. <year>2021</year>;<volume>11</volume>:<elocation-id>4848</elocation-id>.<pub-id pub-id-type="pmid">33649416</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-021-84276-9</pub-id><pub-id pub-id-type="pmcid">PMC7921594</pub-id></mixed-citation></ref><ref id="psp413046-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="psp413046-cit-0047"><string-name name-style="western"><surname>Navarini</surname><given-names>AA</given-names></string-name>, <string-name name-style="western"><surname>Lang</surname><given-names>KS</given-names></string-name>, <string-name name-style="western"><surname>Verschoor</surname><given-names>A</given-names></string-name>, et al. <article-title>Innate immune&#8208;induced depletion of bone marrow neutrophils aggravates systemic bacterial infections</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2009</year>;<volume>106</volume>:<fpage>7107</fpage>&#8208;<lpage>7112</lpage>.<pub-id pub-id-type="pmid">19351895</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.0901162106</pub-id><pub-id pub-id-type="pmcid">PMC2678456</pub-id></mixed-citation></ref><ref id="psp413046-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="psp413046-cit-0048"><string-name name-style="western"><surname>Dalhoff</surname><given-names>A</given-names></string-name>. <article-title>Differences between bacteria grown in vitro and in vivo</article-title>. <source>J Antimicrob Chemother</source>. <year>1985</year>;<volume>15</volume>:<fpage>175</fpage>&#8208;<lpage>195</lpage>.<pub-id pub-id-type="pmid">2858465</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jac/15.suppl_a.175</pub-id></mixed-citation></ref><ref id="psp413046-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="psp413046-cit-0049"><string-name name-style="western"><surname>Qiu</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>KuoLee</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Harris</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>van Rooijen</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Patel</surname><given-names>GB</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>W</given-names></string-name>. <article-title>Role of macrophages in early host resistance to respiratory Acinetobacter baumannii infection</article-title>. <source>PloS One</source>. <year>2012</year>;<volume>7</volume>:<elocation-id>e40019</elocation-id>.<pub-id pub-id-type="pmid">22768201</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0040019</pub-id><pub-id pub-id-type="pmcid">PMC3386929</pub-id></mixed-citation></ref><ref id="psp413046-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="psp413046-cit-0050"><string-name name-style="western"><surname>Silva</surname><given-names>MT</given-names></string-name>. <article-title>Macrophage phagocytosis of neutrophils at inflammatory/infectious foci: a cooperative mechanism in the control of infection and infectious inflammation</article-title>. <source>J Leukoc Biol</source>. <year>2011</year>;<volume>89</volume>:<fpage>675</fpage>&#8208;<lpage>683</lpage>.<pub-id pub-id-type="pmid">21169518</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1189/jlb.0910536</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>